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INTRODUCTION
Recently, important strides have been made
in clinical neurology and clinical neurosurgery, culminating in improved patient care. The last ten
years have witnessed a new sophistication in neuroradiology, and the clear development of neuroophthalmology as a subspecialty. The addition of
the operating microscope to neurosurgery has improved the quaiity of the operation which we can
provide for our patients. A renewed interest in and
study of cerebral vascular disease has aided our
understanding of the pathophysiology of this disorder. Of the various clinical neuroscience frontiers
that have been forged, an improved understanding
of the pathophysiology of brain injury is one of
major significance. Much has been learned, both in
laboratory and in clinical investigation, concerning
the brain's response to insults such as anoxia-ischemia, elevated intracranial pressure, trauma, and
neoplasm. Aiterations in cerebral blood flow and
infracranial pressure in these conditions have been
studied, and more recently studies of the brain's
metabolic response to insults have been conducted.
The clinical goal of improving our treatment of the
insulted brain is becoming more of a reality.
It is to these areas that the speakers at the
27th Stoneburner Lecture Series addressed themselves. The Stoneburner Lecturer was Dr. Thomas
W. Langfitt, Charles H. Frazier Professor and

Chairman of the Division of Neurosurgery at the
University of Pennsylvania. Leading us are Dr.
Langfitt's pioneering efforts and continuing studies
investigating the brain's pathophysiological response
to injury. His first lecture, "The Interrelationship
of Intracranial Pressure, Cerebral Blood Flow, and
Brain Metabolism in Experimental Brain Injury,"
summarized much of his own work and provided
a basic introduction to the program. His second
lecture, "Clinical Advances in the Management of
Patients with Severe Head Injury," demoristrated
how an improved understanding of the brain's response to an insult can improve patient care.
The first part of the program emphasized cerebral vascular disease, and is presented in this issue.
The second part of the program related primarily
to the clinical care of patients with mechanical
brain injury, brain tumors, and seizures, and will
be presented in the following issue of the MCV
Quarterly.

DONALD P. BECKER, M.D.
Professor and Chairman
Division of Neurosurgery
Medical College of Virginia
Virginja Commonwealth University
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The Interrelationship of lntracranial Pressure, Cerebral
Blood Flow, and Brain Metabolism in Experimental
Brain lniury*
THOMAS W. LANGFITT, M.D.
Charles H. Frazier Professor and Chairman, Division of Neurosurgery,
University of Pennsylvania, Philadelphia

This presentation will be concerned with some
of the relationships between intracranial pressure,
cerebral blood flow, and brain metabolism as defined
in animal models (Fig. 1). We will also be concerned
with the pathophysiological changes that occur among
these numerous variables.
We begin with the idea that our greatest concern
is . with normal brain function. The brain, as we
know, functions through the electrical activity of
its neurons, but another way of measuring or defining brain function is in terms of metabolism. For
our purposes, the brain metabolizes only two substances-oxygen and glucose. Apparently, the brain
does not have a store of oxygen nor does it have
a significant store of glucose. It is, therefore, dependent upon a constant supply of these metabolites.
It is also known that the brain is selectively vulnerable to ischemia, that the brain will not tolerate more
than five minutes of cerebral circulatory arrest without irreversible brain damage-a unique feature of
the brain. One can put a tourniquet around the arm,
totally occlude the circulation to the arm for a period
of an hour or two for purposes of doing surgery,
and following the removal of the tourniquet, the
arm functions perfectly normally. The arm contains
bone and muscle, but it also contains nerve and the
neuromuscular junction. What is so unique about
the brain that permits it to tolerate only five minutes

* This is an edited transcription of a lecture presented
by Dr. Langfitt at the 27th Annual Stoneburner Lecture
Series, February 7, 1974, at the Medical College of Virginia, Richmond.
MCV QUARTERLY 10(3): 101 -107, 1974

of ischemia, whereas peripheral nerve and neuromuscular junction can tolerate up to two hours of
ischemia? This is one of the major dilemmas in our
search for the pathophysiological and metabolic basis
of brain injury; as of the moment, we do not really
have a decent answer.
The cerebral metabolic rate of oxygen utilization
and the cerebral metabolic rate of glucose utilization
are dependent upon an adequate delivery of oxygen
and glucose. The amount of oxygen that is available
to the brain is determined by two major factors: the
oxygen content of the blood and the cerebral blood
flow. The amount of oxygen in the blood is, in turn,
determined by the pulmonary function and by the
blood oxygen-carrying capacity. Figure 2 shows the
familiar oxygen-hemoglobin dissociation curve. As
the three curves at pH 7.6, 7.4, and 7.2 reach
asymptote, they do so at a partial pressure of oxygen
(Pa 0 ,) in the blood of about 80-100 mm Hg. When
the Pa 0 , drops below this value, the degree of hemoglobin saturation is significantly influenced by the
pH. The normal patient may show a Pa 0 , value from
80 up to 140 or 200 mm Hg and the saturation of
hemoglobin does not increase significantly, and therefore, in terms of treatment, it does not make much
difference whether the Pa 0 , is 80 or 200. We must
remember, however, that the amount of oxygen available to the brain is a function not only of this value
but also of cerebral blood flow. For example, if the
cerebral blood flow is at a critical level, and the Pao,
drops by only a small amount (from 100 to 80), this
may be quite sufficient to plunge the brain into
hypoxia. It follows, therefore, that in our acutely
l 01
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brain-injured patients, it is necessary to keep the Pa 0 ,
at 100 mm Hg or above. When the Pa 0 , is markedly
decreased (to a value of 40 or 50 mm Hg), the pH
value is of definite significance. At an alkalotic pH
of 7.6 and about 40-50 mm Hg, one can see that
hemoglobin is 853 saturated; whereas in acidosis,
it is about 60% saturated. The important factor here
is that in alkalosis, the hemoglobin hangs onto the
oxygen; it will not release the oxygen as effectively as
in acidosis. Therefore, in a situation where there is
systemic hypoxia, a low Pa 0 ,, and a reduction of
cerebral blood flow approaching a critical value, the
pH of the systemic blood becomes a tremendously
important factor. It is quite possible, as the patient
passes from an acidotic to an alkalotic pH, for the
brain to be again plunged into hypoxia because at

that alkalotic pH, the hemoglobin will not give up
the oxygen as well as it did when the pH was acidotic.
What are the factors which govern the flow
of blood through the brain? The two major ones
include the cerebral perfusion pressure~ordinarily
defined as the inflow pressure (the carotid artery
pressure) minus the outflow pressure (the jugular
vein pressure )-and the cerebral vascular resistance
(Fig. 1 ) . The cerebral perfusion pressure, in turn,
is influenced by the systemic arterial pressure (SAP)
and the intracranial pressure (ICP). The cerebral
vascular resistance, under normal circumstances, is
primarily a function of arterial resistance; they are
therefore called the resistance vessels, the arteries,
and the arterioles. Also, under pathological conditions, cerebral vascular resistance is tremendously
influenced by events that occur within the microcirculation in the capillary bed, in the form of such
things as edema of the wall of the capillaries and
sludging of the intravascular blood.
Figure 3 shows Poiseuille's equation for the flow
of Newtonian fluids through a system of rigid tubes.
This is only roughly applicable to a vascular bed but
is helpful to us as we proceed through this discussion.
Flow "Q" is directly proportional to the perfusion
pressure and to the fourth power of the radius, demonstrating that the diameter or the radius of the
cerebrovascular bed is extremely important in governing the flow through it. If we substitute "R" resistance
for "R" radius, we come up with a rather simple
Ohm's law for the cerebral circulation, which says
that the blood flow is equal to the inflow pressure
minus the outflow pressure divided by the resistance

(I = i) · Under normal circumstances, the perfusion
pressure is defined as the carotid artery pressure minus
the jugular vein pressure. It is very important, how-
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ever, that in the presence of increased intracranial
pressure, this relationship no longer holds. This is
because it has been well demonstrated that as the
intracranial pressure rises, the cerebral venous pressure rises in concert, and the two pressures are essentially equal to all levels of elevated intracranial
pressure. It has become the convention to say, therefore, that the perfusion pressure across the brain, in
the presence of increased intracranial pressure, is
equal to the carotid artery pressure minus the intracranial pressure again divided by the resistance.
If the vascular resistance, the denominator R,
remained the same during a change in perfusion
pressure, cerebral blood flow would passively follow
changes in perfusion pressure, whether the perfusion
pressure was decreased by decreasing blood pressure
or decreased by increasing the intracranial pressure.
We know that this is not true because of the phenomenon of autoregulation. Autoregulation is a
ubiquitous physiological phenomenon which occurs
in the brain, in the pulmonary circulation, the heart,
gastrointestinal tract, and in the kidney. The one conspicuous organ which does not autoregulate is the
skin. We define "pressure" autoregulation as a change
in the diameter of the resistance vessels where blood
flow remains constant in the presence of a change in
perfusion pressure. According to Ohm's law of the
cerebral circulation, if one reduces the perfusion
pressure, the cerebral vessels dilate, thereby maintaining blood flow and if one increases the perfusion
pressure, the cerebral vessels constrict, thereby maintaining the same blood flow. The origin of this particular type of autoregulation is somewhat uncertain,
but our own data, as well as those of many others,
would suggest that it is probably myogenic in origin
and that it is probably a vascular reflex of the small
arteries and the arterioles of the organ.
In man, normal cerebral blood flow is between
50~55 mlf 100 gm/ min. What one sees in man is a
constant blood flow, even as the mean arterial blood
pressure is slowly decreased, until the mean arterial
pressure reaches a value of approximately 50-55 mm
Hg at which point cerebral blood flow falls off
abruptly; the reason it does so at this level is that
the blood vessels are now maximally dilated, and
they cannot dilate any further in response to the
continued decrease in perfusion pressure. It is only
at this point that blood flow bears a passive relationship to perfusion pressure.
One of the questions which we asked ourselves

sometime ago was whether or not the cerebral vessels autoregulate in the same manner to increased
intracranial pressure, decreasing perfusion pressure,
as they autoregulate to decreased arterial pressure,
decreasing perfusion pressure. This seemed extremely
important because so many of our patients with a
wide variety of brain insults develop intracranial
hypertension. In fact, one could probably say that
increased intracranial pressure, as a cause of decreased perfusion pressure, is more common in our
patients than decreased blood pressure, or at least
we can say that the blood pressure is more readily
correctable.
Douglas Miller conducted a series of experiments
with dogs in our laboratory, in an attempt to demonstrate the relationship between autoregulation and
increased ICP. In these experiments, a hollow screw
was put into the torcular Herophili of the dog and
an extracorporeal shunt run from the torcular Herophili to the jugular vein; the remaining venous outflow from the dog's head was occluded. Either an
electromagnetic flow meter or a bubble flow meter
can be used to measure blood flow through the shunt.
This gives one a continuous measurement of cerebral
blood flow (CBF). Further studies have shown that
we are measuring total or nearly total CBF from the
hemispheres and the diencephalon in this preparation.
Some of Miller's data are seen in Figure 4. First, he
decreased the arterial pressure by bleeding the animal
and measured the CBF over a wide range of perfusion
pressures. He was then able to develop an autoregulatory curve, reflected by the open circles. This is a
typical curve of autoregulation showing that there
is no significant change in CBF until the mean arterial
pressure is reduced to about 50 mm Hg. In the same
preparation, he then raised the arterial pressure back
to normal by reinfusing blood. While the arterial
pressure was constant, he raised the intracranial pres-
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sure, thereby reducing the perfusion pressure. That,
then, is represented by the upper curve, the autoregulatory curve for increased intracranial pressure. One
can see that the cerebral vessels do, in fact, autoregulate just as well to increased ICP as they do to decreased SAP and, for unexplained reasons, they
autoregulate somewhat better to increased ICP. These
animals were then subjected to a period of brain
hypoxia by reducing the Pa 0 , to values of about 15- 20
mm Hg for a period of ten minutes. In other words,
the animals were subjected to brain insult. The exact
procedure was repeated. Figure 5 shows a pressure
passive system. Following the cerebral insult, autoregulation was destroyed and the blood flow followed
the perfusion pressure passively whether the pressure
was decreased again by either decreasing blood pressure or by increasing intracranial pressure.
The importance of these kinds of data is that
they demonstrate that when autoregulation is intact
in a patient, he will tolerate large decreases in blood
pressure, shock, or large increases in intracranial
pressure without significant cerebral ischemia. If,
however, the patient has had a brain injury of some
kind and autoregulation is defective, the brain becomes much more vulnerable to either decreased
blood pressure or to increased intracranial pressure.
Trauma to the brain in animals abolishes autoregulation just as hypoxia does. In a study at the
University of Pennsylvania, regional cerebral blood
flow was recorded from the surface of the cat's brain
using the 85 Kr clearance technique, which is very
similar to the 133Xe clearance technique. During the
control period, the blood flow from the cortex was
normal during a drop in mean arterial pressure, showing values as high as 170 down to about 60 mm Hg.
The trauma in this case was minimal, consisting
of directing a 500 millisecond impact of nitrogen
gas through a nozzle at the surface of the brain.

histological damage of the brain; the blood brain
barrier was intact, and the EEG alteration was
slight and immediately reversible. Autoregulation,
however, was impaired, as demonstrated ]Jy the fact
that following the trauma, when arterial pressure
was again varied over a wide range, the characteristic picture of abolished autoregulation, was seen.
There is a second and equally important type
of autoregulation which we term "metabolic" autoregulation, to be distinguished from pressure autoregulation. We can define metabolic autoregulation
as a change in the diameter of the resistance vessels
in order to meet the metabolic demands of the
tissue. A good example of this is a change in cerebral blood flow in the region of the brain during an
epileptic attack. Before the seizure occurs, blood
flow is set for a given metabolic rate of oxygen.
During the seizure, the tremendous increase in
neuronal activity is accompanied by intense vasodilation, markedly increasing the blood flow to that
region of the brain appropriate to the increased
metabolic demands of the epileptic tissue. Whereas
pressure autoregulation is a physiologic phenomenon, most likely a physiologic vascular reflex, metabolic autoregulation, by contrast, is presumably a
chemical phenomenon, probably due to a change
in extracellular pH at the level of the resistance
vessels, the small arteries and the arterioks. As the
neuron increases its activity, it produces more lactate and hydrogen ions. The hydrogen ions rapidly
diffuse out of the neuron, through the extracellular
space, and into the vasoactive vessel; the focal
acidosis causes the vessel to dilate. The linkage
in autoregulation, then, is apparently a hydrogen
ion linkage. This means that if metabolism changes,
a change in blood flow will follow which will be
proportional to the change in metabolism as long
as metabolic autoregulation is intact.
An excellent example of this rule can be demonstrated by what happens in hypothermia (Fig. 6).

Hypothermia
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In hypothermia, the primary change is decrease in
brain metabolism. Under normothermic conditions
of 37°C, CBF is 50 and the cerebral metabolic rate of
oxygen utilization (CMR 0 , ) is 3.5 ml/100 gm/ min.
When one qecreases the CMR 0 , to half that value,
1.75, by decreasing the temperature to 30°C, CBF falls
at the exact same rate-from 50 to 25. If one did not
know about the fall in CMR 0 ,, seeing only that the
blood flow had decreased by one-half, he would say
that the brain was about to become ischemic because
the CBF was at a critical level. This is not true because
CMR0 , has decreased the same amount. Even though
CBF is markedly reduced, it is perfectly adequate for
·
the needs of the hypothermic brain.
We have stated that pressure autoregulation is
sensitive ta various types of brain injury. The same
statement can be made about metabolic autoregulation; thus, with certain kinds of insults, an unlinkage
occurs between metabolism and blood flow and they
go their separate ways. Figure 7 shows some setective
data from ·our patients to demonstrate this fact. All
of these patients were unconscious; most of them had
severe head injuries. In all of these patients the CMRo,
is reduced. The normal value of 3.5 is reduced to as
low as one-third of that value and even lower in two
of the patients. The first patient (BJS) shows a metabolism that is one-third of normal but the mean
CBF is 114 ml/100 gm/ min, the highest mean hemisphere blood flow we have seert in our series. In this
circumstance, the patient has a condition which we
defined a number of years ago as "vasomotor paralysis"- in which there is no metabolic or pressure
control of the cerebral vessels; the tone of the cerebral
vessels has been destroyed. They passively dilate,
thereby increasing cerebral blood flow. It is impossible
to influence this process because both the pressure
and the metabolic control of the blood vessels has been
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destroyed. We see the same thing in the second patient
(ED) with a CBF about 503 above normal, the
CMR0 , again about one-third . normal. The third
patient (JL) has a normal CBF, but it would not be
normal if metabolic aµtoregulation were intact
because the CMR0 , is only one-half normal.
Some of the factors we are most interested in are:
What constitutes a critical l~vel of Pa 0 ,, a critical
level of mean arterial pressure, and a critical level of
CBF for brain function? How much can we reduce
the oxygen content of the blood or the cerebral blood
flow before hypo)l.ic tissue damage occurs? There is
currently an argument as to what criteria should be
used in determining hypoxic tissue damage. Two of
these criteria are a decrease in high-energy phosphates (ATP and phosphocteatine) and an increase
in anaerobic glycolysis. Normally, most of the glucose
that is metabolized by the brain is done so aerobically.
When the amount of oxygen is insufficient to maintain
aerobic metabolism, anaerobic metabolism through
the Embden-Meyerhof pathway increases, and there
is a marked increase in the utilization of glucose.
Generically, hypoxia means insufficient oxygen to
the brain. But hypoxia may be divided into two categories: hypoxic hypoxia, generally due to inadequate
pulmonary function, and ischemic hypoxia, due to
inadequate blood flow. It is possible experimentally,
in .the rat, to reduce the arterial Pa 0 , to a value of
about 25-30 mm Hg at which point a decrease i~
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phosphocreatine occurs. ATP does not change because the phosphocreatine is converted to ATP
temporarily. This process, which is a derangement
in oxidative phosphorylation in the mitochondria,
is one criterion of hypoxic damage. Again, in rats,
if the arterial Pa 0 , is kept constant but the blood
OGI With Decreasing
CBF Due to CSF Infusion
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pressure is dropped, in order to find out what the
critical mean arterial blood pressure is for the maintenance of adequate oxidative phosphorylation, the
valiie is about 30 mm Hg, at which point we see a
drop in phosphocteatine and ATP and art increase
in AMP and ADP.
There have been a number of studies in recent
years, both in nian and in experimental animals,
which show that the critical value for cerebral blood
flow is approximately 45 % of normal. According
to Dr. Sundt's studies on patients undergoing endarterectomy, when the CBF dreipped to a value of
18 or 19, about 45% of normal, there were EEG
changes characteristic of brain ischemia.
There is another new concept regarding the
linkage between metabolism and cerebral blood flow .
We have said that in metabolic autoregulation, the
primary change occurs in metabolism and blood
flow follows due to hydrogen ion linkage. Iri some
of our patient studies, we found evidence to suggest
a reverse mechanism-when blood flow decreased
due to increased intracranial pressure, metabolism
seemed to decrease with the decrease in blood flow.
Teleologically this is extremely important because it
means that if one decreases the CBF slowly enough
over a perieid of time, the metabolism wili decrease
by some unknown mechanism.
Studying the autoregulation curve in the dog with
the experimental design described pteviousiy, where
cerebral blood is measured continuously by the torcular outflow technique, we found that when the mean
cerebral perfusion pressure was decreased to about
50 mm Hg by elevating the ICP, blood flow remained
constant, but below a perfusion pressure of 50, blood
:flow began to fall. We had been concerned mostly
with the horizontal portion of the curve and had
not paid much attention to the falling portiOn. What
we did, therefore, was to increase the intracranial
pressure very carefully in small increments in order to
produce 103 decreases in CBF. At each one of these
levels, we measured the cerebral metabolic rate of
oxygen and glucose. Figure 8 shows the data regarding
the CMR0,. On the abscissa, we have CBF beginning
with the normal value of close to 50; CMR 0 , is on
the ordinate. We see that when CBF has been decreased to about 703 of control, CMR0 , begins to
fall and follows CBF down to approximately one-fifth
of control. This decrease in CMR 0 , occurs at values of
CBF 703 of normal, far above those 'values required
to provide the brain with art adequate amount of
oxygen. At this point, therefore, it seems clear to us
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that the decrease in cerebral metabolism is not a
manifestation of brain damage; rather it appears to be
due to some kind of metabolic control mechanism
which tends to turn off the brain as the oxygen supply
is reduced, a protective mechanism intrinsic to the
brain.
Figure 9 shows some of the dl:lta fqr the glucose
-not quite so impressive, but again we see a decline
in the cerebral metabolic rate of glucose with decreasing CBF. When we look at the area of the
curve where CBF is 15 ml/ 100 gm/ min, we see
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that this is the point where there is an increase
in glucose metabblism. This is a manifestation of
the onset of th~ 1 hypoxic tissue damage-anaerobic
glycolysis-which occurs at about 45 % of control
CBF. Figure 10 shows this more clearly in the form
of the so-called glucose index. Normally the brain
metabolizes about 90-95% of its glucose aerobically. One can see that at a value of 20~22, about
45 % of control CBF, there is a marked change in
the oxygen glucose index-a marked increase in
anaerobic glycolysis.

Arteriography of Cerebrovascular Disease*
FREDERICK S. VINES, M.D.
Associate Professor of Radiology and Neurology; Chief, Section of Neuroradiology, Medical College of Virginia, Health Sciences Division of Virginia Commonwealth University,
Richmond

Advances in reconstructive va~cular surgery
have increased the importance of accurate angiographic demonstration of the extracranial vascular
tree. The limitations of the clinical examination
are well recognized and make it essential that complete angiography be obtained prior to contemplated
surgery. The locus of cerebral involvement may be
determined clinically, but the site and extent of
vascular disease in a surgically accessible location
must be confirmed. The role of the angiographer
is, therefore, twofold: Firstly, he must be able to
safely perform complete angiography with adequate
evaluation of the multiple sites of possible involvement; secondly, he must be aware of the j::>athophysiological changes which may occur and recognize
·the techniques and pitfalls he may encounter in
delineating these changes. The present communication will describe the more common findings observed during angiography, along with some pitfalls
the angiographer and clinician may encounter.
The example of carotid stenosis in Figure lA
certainly would be considered by most to be a
surgical candidate with a remaining internal carotid
lumen of less than 1 mm; however, the patient shown
in Figure lB, with smooth carotid artery stenosis
narrowing the lumen by approximately 60%, may
not be a candidate for operative intervention. Extracranial surgery was originally performed based on
a theory of decreased cerebral blood flow, relative
to an arbitrary degree of narrowing of the proximal
arterial lumen. Thus, factors such as hypotension
or cardiac arrhythmias which would result in decreased flow were considered to produce cerebral

* Presented by Dr. Vines at the 27th Annual Stoneburner Lecture Series, February 7, 1974, at the Medical
College of Virginia, Richmond.
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symptoms in the territory supplied by the stenotic
vessel. This "stenotic theory" is now considered
to play a minor role irt the production of symptoms
of cerebral ischemia ( 1). A significant change has occurred in recent years, so that now the patient with
an "ulcerated plaqµe" and recurrent symptoms distal
to this lesion is considered to be the prime candidate for extracranial carotid artery surgery. These
ulcerated plaques are considered to be a source of
cerebral emboli from clumps of blood elements or
atheromatous materials which have developed from
an area of irregularity and ulceration in a preexisting
plaque. This explains the recurrent episodes of
cerebral ischemia and the symptoms that may be
present with a minor plaque or stenosis. Several
· examples of ulcerated plaques are seen in Figure 2.
It is imperative that the carotid artery be evaluated
carefully in multiple angulations, since these ulcers
may at times be quite small and seen in only one
projection. It is true, however, that most of the
atherosclerotic disease and subsequent ulcer formation is on the posterior wall and the critical view
is a lateral projection.
Another common problem in evaluating the
extracranial carotid artery is the presence of an
"irregular" plaque. This is a somewhat arbitrary
designation and indicates only that there is no
single focal area of ulceration (Fig. 3). The angiographer must be completely aware that the ulceration
itself, however, may be filled with debris at the time
of the contrast injection and should not be surprised
if the pathological sample shows a much more
irregular and ulcerated lesion. Additionally, a perfectly smooth carotid stenosis angiographically may
at the time of surgery have a focal area of ulceration.
Some authors consider that an irregular plaque
cannot be differentiated from an ulcerated plaque
MCV QUARTERLY 10(3): 108·113, 1974
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Fig. IA- Severe internal carotid artery stenosis.

and that both should be treated as possible sources
for cerebral emboli. This finding has been estimated
to occur in 10-30% of the cases, but one might
consider that this incidence could be reduced by
utilizing multiple projections of the carotid bifurcation (2). Thus, one should examine the carotid bifur-

Fig. IE-Moderate internal carotid artery stenosis with
smooth borders.

'
Fig. 2A, B-"Ulcerated" internal carotid artery plaques. The atherosclerotic plaque projects into the arterial lumen with
the collection of contrast in the "ulcer" crater (arrow).
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arch aortography, also severely limit its use alone
to evaluate patients suspected of having vascular
lesions.
Others have commented on the frequency of
other pathological findings in the intracranial circulation of a patient studied for clinically suspected
extracranial vascular disease. With more sophisticated brain scanning techniques and ancillary tools
of clinical examination in recent years, however,
the incidence of this observation is certainly lower
than the previous reports of 5 % . We do suggest
routine angiography of the intracranial as well as
the extracranial circulation, therefore, but for evaluating the distal vascular bed rather than for primary
evaluation of an unsuspected subdural hematoma
or neoplasm.
Complete occlusion of the internal carotid
artery is now considered by most surgeons to be
a nonoperable condition ( 3) . The incidence of intracranial hemorrhage following reestablishment of circulation after an acute occlusion has made this
procedure hazardous, and the poor success rate in
reestablishing circulation in a chronically occluded
lesion has made most surgeons unwilling to attack
this lesion. There are, however, cautions of which
Fig. 3- Irregular internal carotid artery plaque. There
is mild stenosis with irregular borders of the contrast
posteriorly.

cation in at least three views-the frontal, lateral,
and oblique. The angiographer should also have a
low threshold for performing additional views if
necessary for adequate evaluation.
Unfortunately, the presence of an ulcerated
plaque does not indicate that this is the cause for
the patient's symptoms. We are certainly observing
"asymptomatic" ulcerated plaques in a large number of cases studied for other clinical problems.
Conversely, there may be distal vascular lesions
that are equal in importance to the bifurcation
lesion. The second most common site of carotid
atherosclerotic disease is its cavernous portion. Severe stenosis and ulcerations at this site may preclude surgical repair of the cervical carotid artery.
One may also see stenosis of the middle cerebral
artery or proximal anterior cerebral artery that
would limit surgical therapy. Careful subtraction
may be necessary when the vessel is not well delineated and free from the dense bony structures
at the base of the skull. The small size of these
ulcers and overlapping of vessels, which occurs with

Fig. 4-Distal internal carotid embolus (white arrow).
An area of infarction with arteriovenous shunting is present
(black arrow). Avascular areas of branch occlusions are
present in front of and behind the area of luxury perfusion.
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..
Fig. SA, B-Frontal and lateral views of major branch occlusion of the middle cerebral artery (arrow).

one must be aware when evaluating what appears
to be complete occlusion of the cervical portion of
the internal carotid artery. The typical occluded
internal carotid artery will obtain its intracranial
filling via the opposite anterior cerebral artery or
by the supraorbital branches of the ipsilateral external carotid, filling the ophthalmic artery and
cavernous carotid in a retrograde manner. "Pseudoocclusion" of the internal carotid artery may occur,
however, when the stenosis is so severe that only
a trickle of contrast extends beyond the obstruction,
even though the internal carotid lumen. immediately
distal to the stenosis is normal. This faint linear
accumulation of contrast may be obscured by over-

lying external carotid branches and may not reach
the supraclinoid carotid for several seconds. Therefore, every apparent internal carotid "occlusion"
should have a series prolonged for 10'-15 seconds
with a careful search for any patency into the skull.
The significance of cerebral emboli from other
sources is also assuming increased clinical importance. Certainly most of the emboli will arise from
a cardiac valve or an endocardial surface but increasing interest is developing regarding the possibility of emboli from the pulmonary veins. Large
emboli may obstruct the carotid artery itself and
this possibility must be carefully evaluated whenever
there is obstruction other than at the bifurcation

Fig. SC, D-Frontal and lateral view of recanalization of this occlusion. Minor narrowing of the lumen is still present
(arrow). An avascular area of a peripheral branch occlusion persists in frontal operculum.
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Fig. 6A-Basilar artery occlusion (black arrow). Collateral filling of superior cerebellar arteries has occurred
via cortical anastomosis with the posterior inferior cerebellar arteries.

or in the cavernous carotid, for example, the common carotid or the midcervical carotid. These
emboli may also lodge in the intracranial vascular
tree, creating a flow deformity (Fig. 4) with re-

Fig. 68-Embolic basilar artery occlusion (arrow).

current symptomatology as fragments of the embolus migrate distally. An area of "luxury perfusion"
is seen peripheral to the obstructed frontal opercular
branch with a poorly defined stain and early venous
filling. This patient developed further left hemisphere symptoms, and pathological confirmation was
obtained of large hemorrhagic infarction involving
most of the left hemisphere. Not all emboli result
in this course, however. The patient in Figure 5
developed acute occlusion of the middle cerebral
artery, two of the redundant trifurcation branches being occluded. Subsequent repeat angiography in several days, however, shows that this middle cerebral
artery has recanalized and only a single frontal
branch is now occluded. This illustrates a major reason for the frequent normal angiographic findings in
the stroke syndrome. Emboli may be rapidly lysed
and may migrate distally, allowing a positive angiographic diagnosis to be obtained only in the first few
hours after the onset of clinical symptoms.
Basilar artery occlusive disease is a more serious
problem, usually with a fatal outcome. Recent clinical data indicate, however, that some of these people
survive with a reasonably minor neurological deficit.
The patient in Figure 6A developed signs of severe
upper midbrain dysfunction, with angiographic findings of complete occlusion of the basilar artery
just below the origin of the superior cerebellar
arteries and retrograde filling via the posterior inferior cerebellar arteries. A recent case illustrates
a surgically altered course with a large basilar artery
embolus (Fig. 6B). There is a filling defect ob-

Fig. 6C-Postoperative patency of the basilar artery and its
branches.
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structing the distal basilar artery with markedly
delayed flow. This view was obtained nine seconds
following the injection of contrast. Collateral filling
of the superior cerebellar arteries occurred via the
posterior inferior cerebellar arteries. There was no
filling of the posterior cerebral arteries or the dome
of the basilar artery from either carotid injection
or from collateral vessels. The patient underwent
surgical removal of a large basilar artery embolus
that was extending into both posterior cerebral arteries. The postoperative arteriogram (Fig. 6C)
shows restoration of patency of the basilar artery
and posterior cerebral arteries. This procedure did
not alter the ultimate outcome of the patient but
does indicate the development of surgical techniques
and procedures which allow the performance of this
em bolectomy.
Summary. The importance of complete angiographic studies in patients suspected of extracranial vascular disease has beep. emphasized.
Examples of a variety of lesions of the intracranial
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and extracranial circulation have been shown. It is
important that the angiographer obtaip. adequate
visualization of the circulation cephalad to the
aortic arch with awareness of the type of lesion and
technical problems that may be encountered. It
is only in this way that further understanding of the
"stroke syndrome" can be ~ttained with appropriate
therapy.
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The Neuro-Ophthalmology of Cerebrovascular
Disease*
JOHN W. HARBISON, M.D.
Associate Professor, Department of Neurology, Medical College of
Virginia, Health Sciences Division of Virginia Commonwealth
University, Richmond

The neuro-ophthalmology of cerebrovascular
disease is a vast plain of neuro-o'phthalmic vistas,
encompassing virtually all areas of disturbances of
the eye-brain mechanism. This paper will be restricted to those areas of the neuro-ophthalmology
of cerebrovascular disease which one might consider advances in its clinical diagnosis and treatment.
Most practitioners of medical and surgical neurology give little thought to that aspect of medicine
generally accepted as the ideal approach to any
disease-prevention. Usually when one is presented
with an illness of the central nervous sys~em, it
seems to be a fait accompli. Although prevention
is by no means new, certain aspects of it qualify
as advances. There is one advance in cerebrovascular disease in which prevention plays a significant
role. This is the recognition and surgical correction
of atherosclerotic lesions of the extracranial carotid
system which threaten the patient with that bane
of antiquity-the "stroke."
Neuro-ophthalmology, largely by virtue of the
carotid origin of the ophthalmic artery, plays a
valuable role in the ~ecognition, evaluation, therapy,
and prognosis of disease of the extracranial internal
carotid artery. Even this markedly restricted aspect
of the neuro-ophthalmology of cerebrovascular disease is far too extensive to review adequately in
this paper. I have therefore selected for discussion
certain aspects of our nei.iro-ophthalmic approach
to extracranial carotid disease. Some of these are
well known; others are less obvious and frequently
overlooked in our evaluation of patients. Tpey all,

* Presented by Dr. Harbison at the 27th Annual
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however, are important pieces to the puzzle the
patient may present. A wide variety of afflictions
of the eye occur by virtue of its arterial dependence
on the internal carotid artery. It is also logical to
assume that changes in the distribution of the
ophthalmic artery may reflect changes taking place
in other chanqels of the internal carotid arterythe middle cerebral, the anterior cerebral, and depending upon anatomic variations, the posterior
cerebral artery. This paper will discuss these afflictions, those common as well as rare, those well
recognized, and those frequently overlooked.
Historically, the recognition of the eye as an
index of cerebrovascular disease presents an interrupted course. Virchow is credited with the first
autopsy correlation of ipsilateral blindness with
carotid thrombosis; Gowers in 1875 demonstrated
embolization as a source of central retinal artery
and middle cerebral artery occlusion, resulting in
monocular blindness and contralateral hemiplegia;
Chiari followed in 1905 with his identification of
the carotid bifurcation as a common source of
atheromatous emboli to the cerebral circulation; in
1914 Ramsey Hunt emphasized the significance of
transient symptoms involving the ipsilateral eye and
contralateral extremities as strong evidence of
ischemia. Thus by the turn of the century, the
stage was set for incrimination of the extracranial
internal carotid artery as a major source of "strokes."
Embolization was known as a basis for ipsilateral
eye and contralateral extremity symptoms and
signs; the carotid bifurcation was known as a source
of emboli; and transient symptoms were recognized
as reflections of ischemia-a stroke prodrome or
warning was discovered. Yet it was for Fisher in
1951 to rekindle interest in extracranial carotid
MCV QUARTERLY 10(3): 114-117, 1974
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disease with his emphasis on transient ipsilateral
visual and contralateral extremity symptoms as precursors of future strokes. It is this reawakening
which has led directly to the current advances in
the medical and surgical neurologic care of extracranial internal carotid disease.
Amaurosis fugax, "fleeting blindness," has become a household phrase of those involved in the
diagnosis and care of patients with carotid disease.
The clinical picture of amaurosis fugax is reasonably
straightforward. It consists of transient monocular
painless visual loss. Much has been made of the
character, duration, mode of onset, and resolution
of the visual loss. Perhaps too much emphasis has
been placed on such characteristic patterris as the
window shade or picket fence effect. As a result,
we find that many patients we see have already been
"well educated" by housestaff. The potential patterns
of visual loss are many. They include 1) · an upper
altitudinal loss o( vision, "the window shade"; 2) a
lower altitudinal loss of vision, "the picket fence";
3) a generalized peripheral loss of vision; 4) a total
blackout of vision; and 5) a central blurring of
vision. The onset is most frequently abrupt; the
curtain seldom drops or rises slowly. Occasionally,
the event is associated with photopsia-crude visual
hallucinations, usually 1n the form of showers ,or
flecks of light but suggestions of geometric character
will sometimes be seen. The key factors differentiating this photopsia from occipital disease and migraine are its clear unilaterality, the patient's age,
and a detailed analysis of the history, which excludes
migraine as a consideration and supports amaurosis
fugax. The event need not be simply a blackout;
dimming with a sensation of color may occur with
green and yellow having popularity. In my experiences, color sensation has been uncommon.
The duration is generally brief, lasting two
or three minutes, or rarely, five-to-ten minutes. We
have found a common tendency for patients to
misjudge the time sequence with frequent exaggeration of the period of visual loss. As this tendency
to misjudge the duration of visual handicap may
be bothersome diagnostically, we have adopted a
simple time confirmation method. It consists of
instructing the patient that you are going to begin to
count and he is to assume that this is the onset
of his visual symptomatology. We encourage the
patient to "relive" the experience and With the use
of our verbal clock, determine the average duration
of visual loss. The rule is to find a duration of from
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one and one-half to two or three minutes despite
the patient's initial claim of five, ten minutes, or
longer of impairment. A watch second hand or stop
watch could also be used; however, the vocal metronome seems helpfuL
Although empP.asis has been placed on the
association of ipsilateral eye and contralateral extremity signs and symptoms, it should be recognized
that their actual temporal association is unnecessary
diagnostically and infrequent clinically. The eye
symptoms and signs in isolation as evidence of
cervical internal carotid disease are, in ali likelihood,
far more common than many practitioners realize.
The work of Lubow and associates at Ohio State
regarding "retinal strokes" underlines this concept.
On rare occasions, transient homonymous visual
impairment may be a reflection of internal carotid
disease by virtue of a carotid origin of the posterior
cerebral artery. Correct diagnosis will depend upon
associated symptoms and signs.
The precise pathophysiology of these brief
alterations of visual ftinction continues to excite
some debate. It seems certain that most are based
upon emboli of either platelet aggregates or atherosclerotic debris. The exact point at which the embolus works its evil is less certain. As will be
discussed, visible emboli in central retinal arterioles
must play a role; whether they are the sole inciting
force is less certain. Emboli to the choroid, not
apparent clinicaily, may be. important. The role of
dynamic reduction of blood flow in the production
of visual symptoms of carotid disease is probably
small. It does, however, in selected but infrequent
instances, probably play a significant role. Total
carotid occlusions obviously cause some transient
visual symptoms; generally, the symptoms cease
following the stabilization occurring postocclusiori.
Our diagnostic evaluation of patients with
symptoms of transient visual loss consists of the
careful analysis and integration of the specific physical signs with the presenting and elicited symptoms.
Although we have defined amaurosis fugax as
transient painless monocular visual loss, occasionally,
residual deficits of vision remain. In addition, a
number of patients with cervical internal carotid
disease present not with transient ipsilateral eye
symptoms but with fixed deficits.
Needless to say, the diagnostic evaluation of
all patients with eye symptoms and signs suggesting
ipsilateral carotid disease must begin with documentation of visual function-this includes best
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corrected visual acuity, pupillary reactivity, and
quantitative visual field evaluation. Although we
palpate neck vessels, much less than total absence
of vessel pulsation is lightly regarded. Auscultation
is considered an important adjunct, with realization that bruits at sites other than the suspected
symptomatic area may be significant. A bruit in
isolation, however, is of dubious benefit.
The final , but perhaps most valuable, aspect
of the neuro-ophthalmic diagrtostic evaluation of
patients suspected of harboring atherosclerotic disease is the dilated funduscopic examination with the
recording of retinal artery pressures. If one is fortunate enough to be present during an amaurotic
event, funduscopy may reveal white platelet emboli or
bright cholesterol plaques passing through the central
retinal arterioles. As this is a distinctly uncommon
opportunity, one must usually be satisfied with residue which remains behind-most commonly, bright
cholesterol material lodged at. arteriole bifurcations.
Hollenhorst, who first recognized the significance of
retinal emboli in 1961 , recorded a 33% incidence of
these "Hollenhorst plaques" in patients with symptomatic cerebrovascular insufficiency.
Ophtha]modynamometry (ODM) should be
routinely performed .following a thorough funduscopic survey. The technique of ODM was first
devised by Baillart in 1917 to measure central
artery pressure. Svien and Hollenhorst popularized
its use in 1956. One must keep in mind that ODM's
are not a measuremertt of absolute pressures. This
is, by and large, not a disadvantage as their primary
benefit is a relative comparison of one eye with
the other. We, as do many others, commonly record
only the diastolic reading and routinely perform
the OI)M's in the sitting position. Before we consider the asymmetry significant, we require a 15 %
difference when the readings are below 40 units and
a 20% difference when the readings are above 40
units. Any readings below 20 units are considered
abnormal. The basic mechanism of ODM is the
simple increase of intraocular pressure to levels
above the central artery pressure. Needless to say,
either increased or decreased intraocular tension
will falsely alter the reading obtained. For this
reason, tonometry-the recording of intraocular
pressure-is essential in conjunction with ophthalmodynamometty. Despite great care in technique,
false negative readings abound. Our experience has
suggested that significant ophthalmodynamometric
asymmetry indicates extreme stenosis, if not actual
occlusion, of the symptomatic internal carotid ar-

tery. Ophthalmodynamometry plays a definite,
though limited, role in the diagnosis of atherosclerotic cervical internal carotid disease. With the value
of ODM's in perspective, we continue to use them
routinely.
A discussion of amaurosis fugax is not complete without a brief review of the differential diagnosis. Although almost all transient monocular visual
loss is due to internal carotid arterial disease, there
are other considerations which include temporal
arteritis , migraine and migraine equivalents, glaucoma, papilledema, Raynaud's disease, and other
emboli. It is seldom difficult to identify these additional sources of transient monocular visual loss
if they are appropriately sought.
Amaurosis fugax , although the hallmark of
occlusive internal carotid disease and certainly its
most common symptomatic neuro-ophthalmic presentation, is by no means the only eye manifestation encountered in internal carotid vascular disease.
The following discussion will describe a number of
less commonly recognized clinical syndromes caused
by occlusive internal carotid disease.
Retinal stroke, although commonly an integral
aspect of the syndrome of amaurosis fugax, certainly occurs in the absence of prior symptomatic
transient monocular visual loss; there can be little
doubt that the occurrence strongly suggests atherosclerotic disease of the cervical internal carotid
artery. The work of Lubow and associates at Ohio
State in 1972 has shown, angiographicaily, a 95%
incidence of carotid bifurcation disease in patients
having retinal strokes as compared to asymptomatic
age-matched controls in which angiography demonstrated a 25 % incidence of bifurcation abnormalities. What do re.tinal strokes consist of? They
consist of occlusive disease of the retina, previously
relegated to ophthalmic practice. It has become apparent, however, that many "retinal strokes" are
of embolic origin and manifest cholesterol plaques
exactly like those seen in amaurosis fugax.
Central retinal artery and artery branch occlusions, as well as more distal cholesterol emboli,
producing peripheral defects frequently unappreciated by the patient, constitute the retinal stroke.
Their clinical manifestation is abrupt, usually painless, persistent monocular visual loss. Blindness and
optic atrophy frequently follow retinal strokes. In
our brief historical review, one may recall Gowers'
allusion to ipsilateral optic atrophy and blindness associated with contralateral hemiplegia. Carotid disease is obviously likely with this association . What
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must not be forgotten is that isolated blindness and
optic atrophy may also reflect cervical internal carotid disease. Other funduscopic alterations causally
related to cervical or extracranial internal carotid
disease occur. It is not commonly recognized that
ipsilateral carotid occlusive disease may serve to prevent the expression of both hypertensive and diabetic
retinopathy. When a patient is seen with remarkably
asymmetric hypertensive or diabetic retinopathy, consideration of the possible presence of occlusive internal carotid disease should follow .
Ischemic retinopathy, recognized as evidence
of chronic retinal ischemia by Kearns and Hollenhorst in 1963, is a syndrome consisting of a retinal
picture similar to diabetic retinopathy with dilated
veins, some resultant blot hemorrhages and microaneurysms, low ophthalmodynamometric values, and
at times, severe orbital pain. Ischemic retinopathy
can be differentiated from diabetic retinopathy by the
fact that it is unilateral and that there is no biochemical evidence of diabetes mellitus. Obviously, diabetes
and the Kearns ischemic retinopathy may coexist.
The significance of ischemic retinopathy is its reflection of severe impairment of internal carotid
as well as collateral circulation to the eye and
orbit. Not uncommonly, the major trunks from the
aortic arch are the site of the vascular occlusion.
There are three additional presentations of
eye signs reflecting occlusive vascular disease which
generally indicate, as does ischemic retinopathy, a
more severe and diffuse vascular embarrassment of
orbital as well as central retinal circulation. These
are ischemic inflammation, "pseudouveitis"; ocular
hypotony; and neovascular glaucoma.
Ocular inflammation resembling uveitis may
result from chronic ocular ischemia secondary to
diffuse occlusive vascular disease, involving not only
the internal carotid but the collateral channels as
well. This syndrome is characterized by dilatation
of episcleral veins, a turbid anterior chamber, iris
synechiae, corneal precipitates, and edema. On
occasion, vitreous hemorrhage may occur and
cataracts may rapidly develop.
In circumstances where acute reduction of
orbital blood flow affects more specifically the
ciliary body, reduced production of aqueous humor
results leading to ocular hypotony and potentially
phthisis bulbi.
Chronic ischemia in the eye is also a stimulus
to new vessel production. Prolonged reduction of
orbital blood flow may result in proliferation of
neovascular tissue on the surface and angle of the
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iris. This will often culminate in occlusion of the
anterior chamber angle and a malignant form of
secondary glaucoma referred to as neovascular or
hemorrhagic glaucoma.
It is obvious that the last three syndromes
reflecting eye involvement, secondary not simply
to carotid stenosis but most certainly to more severe
carotid occlusive disease, as well as occlusive disease
of the usual orbital collateral channels, may occur
either in sequence or in combination. Their incidence in reality is quite low. Ischemic retinopathy,
a less severe manifestation of the same process, is
reported in only 5 % of unilateral carotid occlusions.
It is wise, however, to realize that eye signs other
than simple transient or permanent monocular visual
loss may point to disease of the cervical carotid
vessels.
In conclusion, one should mention the occurrence of unilateral Homer's syndrome in a not
insignificant number of unilateral internal carotid
occlusions. This quite likely represents involvement
by edema and ischemia of the carotid sympathetic
plexus in the adventitia.
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Medical Management of Cerebral Vascular Disease*
WILLIAM K. HASS, M.D.
Professor of Neurology, New York University, New York, New York

I shall begin with two axioms and a few definitions and, subsequently, offer conclusions and a few
words to the medical lexicon. Axiom # 1-there
is no such thing as a CVA. In the year 1974,
with cerebral angiography widely available and with
computerized axial transverse tomography coming
into its own, CVA can only stand for "confused
vascular analysis." Axiom #2-the best time to
treat a stroke is before it happens or at the very
least, before it significantly disables the patient.
Ultimately, there are two fundamental kinds
of stroke: cerebral infarction or ischemia and cerebral hemorrhage. The first relates to a focal cerebral
dysfunction due to transient or persistent insufficiency of blood in a given cerebral vascular territory.
The second relates to the often massive escape of
blood into the brain parenchyma, the subarachnoid
space, or both locations. From a practical standpoint, a lumbar puncture which fails to reveal blood,
and particularly xanthochromia, effectively rules out
almost all cerebral hemorrhages and suggests the
process of cerebral ischemia or infarction. The two
major kinds of stroke can be differentiated clinically
without too much difficulty. On the other hand,
the problems of etiology, pathogenesis, and management continue to challenge the clinician. Since
strokes due to cerebral ischemia and/ or infarction
account for 75% or more of all observed strokes,
and because of the preponderance of strokes of this
variety and the limits of space, we will confine our
attention here entirely to the problem of cerebral
ischemia and infarction.
If one is to classify strokes due to cerebral
ischemia, one may do so in terms of the nature
and duration of the episode, on the one hand, and
the vascular territory of involvement, on the other

* Presented by Dr. Hass at the 27th Annual Stoneburner Lecture Series, February 7, 1974, at the Medical
College of Virginia, Richmond.
118

hand. When an episode of focal cerebral dysfunction
occurs which is related to a given vascular territory,
persists for minutes to at most 12-24 hours, and
then vanishes completely, we say that the patient
has had a transient ischemic cerebral attack. If the
episode involves the vision of one or the other eye
(patients often state that it seemed as though a shade
was drawn across the vision of the eye), we state
that the patient has had a transient retinal ischemic
attack or amaurosis fugax. Onset over a period of
a few seconds to a few minutes characterizes these
episodes. If an episode develops either quickly or
over a period of minutes to hours and if the focal
deficit persists for many days and then largely but
not completely clears, we say that the patient has
had a transient ischemic episode with incomplete
recovery. From a pathogenic and treatment standpoint, the transient ischemic episodes and transient
ischemic episodes with incomplete recovery are
considered to be a single entity. If the focal deficit
appears over minutes to hours or sometimes even
days and persists, severely disabling the patient, we
say that the patient has suffered from a completed
stroke. In this situation, cerebral infarction, characteristically, is the underlying cerebral pathology.
Quite frankly, most neurologists in the field
at this time can point to no satisfactory treatment
for the completed stroke, except for good medical
care with attention to cardiopulmonary function,
management of blood pressure, withholding of oral
intake, and treatment entirely by intravenous fluids
during the acute period, particularly when the patient is mildly obtunded. These efforts have stood
the test of time. More specific therapy, such as
stellate ganglion block and C0 2 inhalation, as well
as streptokinase and urokinase, have fallen by the
wayside, some buried by their own initial advocates.
Nevertheless, the search must go on. In only one
area, that of stroke in evolution involving the brain
stem, has a specific form of therapy, anticoagulation,
MCV QUARTERLY 10(3): 118-122, 1974
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reduced mortality and morbidity to a degree-tenfold-which causes the Mayo group to advocate
its use with vigor in this specific instance.
Ischemic strokes are also defined in terms of
territory of presumed blood vessel involvement. The
two major territories are those of the carotid middle
cerebral-anterior cerebral system and the vertebrobasilar system. Carotid territory dysfunction is characterized by one or more of the following: ipsilateral, transient or rarely persistent visual loss due
to the fact that the ophthalmic artery is the first
branch of the carotid artery, contralateral weakness,
contralateral cortical sensory dysfunction, contralateral hemianopia, and in almost all of the righthanded individuals and in some 60% of left-handed
individuals, aphasia or dysphasia-the impairment
of the faculty of language when the left internal
carotid artery territory and left cerebral hemisphere
are involved. The words of the psalmist, "If I forget
thee, O' Jerusalem, let my right band forget its
cunning and let my tongue cleave to the roof of my
mouth," characterize the classic dominant carotid
territory lesion.
Strokes due to vertebrobasilar involvement
rarely give rise to the classic crossed syndromes so
familiar in neuroanatomy texts, such as Weber's
syndrome, characterized by an ipsilateral third nerve
palsy and a contralateral bemiplegia. More often, one
or more of the following characterize ischemia in
the vertebrobasilar territory: alternating bemiparesis,
ataxia, diplopia, dysarthria, hiccup, alterations in
respiratory pattern, nausea and vomiting, and pupillary changes.
Many things can cause transient or persistent
focal cerebral or retinal ischemia. Particularly when
ischemia is encountered in younger individuals, one
may suspect a primary cardiac source involving
the valves as in rheumatic endocarditis or verrucous
endocarditis, left atrial thrombosis in rheumatic
heart disease with mitral stenosis and atrial myxoma.
Changing pulses and/ or chest pain should suggest a
dissecting aneurysm. Atrial fibrillation should always
suggest a primary cardiac source. A variety of systemic diseases including polycythemia, thrombotic
thrombocytopenic purpura, idiopathic thrombocytosis, and granulomatous angiitis, as well as disseminated intravascular coagulation should be thought of
in all cases; but the garden variety of transient or
persistent stroke due to focal cerebral ischemia, as
seen in the hospital, usually appears in a seemingly
healthy male at an average age of 62. The incidence
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of what is still fashionably called "cerebral thrombosis" in this patient population approaches 1% per
year in the age group 65-74. Almost 40% of these
patients have a history of increased blood pressure,
20% a history of diabetes, and at least 50% will give
a history of a previous transient cerebral iscbemic
episode. Hypertension, diabetes, and previous TIA's
constitute the triad of the stroke-prone profile;
indeed, 30-37% of patients with transient ischemic
episodes will exhibit a full-blown completed stroke
within five years if untreated.
Our New York University (NYU) study of
the surgical treatment of transient and persistent
focal cerebral ischemia revealed approximately onethird of the patients with transient ischemic attacks,
one-third with transient ischemic attacks and incomplete recovery, and one-third with completed strokes .
Arteriograpbic studies had borne out the fact, first
extensively studied by Hutchinson and Yates, that
the garden variety of transient or persistent focal
cerebral iscbemia is related more to observable
extracranial atberomatous arterial disease, particularly in the carotid arteries than to primary intracranial occlusive disease and indeed, more to stenosis than to occlusion.
Various studies have defined the preferred sites
of atheromatous disease in the surgically approachable areas of the brachiocephalic system. Predominance of the carotid bifurcation involvement is apparent with stenosis of greater than 30% being
present in more than one-third of all right and
one-third of all left carotid arteries. Frank occlusion
is much less common. In the intracranial circulation,
observable stenotic lesions in the carotid territory
fall tenfold. The values for occlusion in the distal
carotid artery are inflated because in many cases
occlusion is taken to represent propagation of clot
from the origin of the internal carotid artery. Proximal vertebral artery involvement bas been seen in
approximately 20% of all vertebral origins on the
right and left. Considerably less often, but probably
symptomatically much more important, is stenosis
which is seen distally in the vertebrobasilar system.
There is no clear-cut relationship between
frank carotid occlusion and the degree of neurological deficit. Another problem encountered is that
patients often do not present with a single high
grade stenotic lesion in the artery appropriate to
their cerebral symptoms; rather they present with a
complex mixture of arterial lesions which may give
rise to the exact same symptomatology.
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In our NYU experience with 400 patients, we
tried to group all of the cases into a meaningful
framework. It is understood that every patient's
vascular fingerprint is individual and that there are
almost as many patterns of lesions as there are
symptomatic patients. It was interesting that when
we classified a lesion as a lesion, if the stenosis occupied more than 30% of the vascular lumen in
any x-ray plane, 17 % of the patients showed no
lesions which occupied 30% or more of a vessel
lumen after four-vessel angiQgraphy. The existence
of this pleomorphic pattern of vascular lesions,
paired with the fact that 50% of all individuals
over the age of 50 have a major stenosis of at least
one of the four major vessels (two carotid and two
vertebrals, all leading to the brain), and that only
10% ultimately become symptomatic, offered numerous roadblocks to our eventual understanding
of the pathogenesis of at least most of the carotid
territory transient and persistent strokes.
Until the 1960's, it had been customary to
attribute the patient's symptoms to the degree of
stenosis or occlusion of the vessel developing by
one or more pathogenic processes, which led to
marked luminal compromise and then, presumably,
to symptoms which developed in proportion to the
degree of collateral circulation possessed by the
patient. Surgical studies compared with angiographic
observations, however, began to question this
stenotic theory of pathogenesis of strokes. A new
concept of pathogenesis, best characterized as the
embolic theory, arose.
The sources of arterial emboli from lesions,
which may occupy less than 30% of the vascular
lumen formerly considered to be insignificant, were
as follows: necrotic plaque, clot from ulcer, and
platelet emboli from ulcer. Ulcerations can easily
be seen on angiography, in the initial phases associated often with high grade stenosis, and the dye
can also be seen hung up in the ulcer crater. Distal
propagation of thrombus, significantly compromising
the internal carotid lumen, can be seen. Radiologic
evidence from NYU disclosed 24 ulcerative and 22
irregular lesions at the origin of the internal carotid
arteries of the neck in the cerebral angiograms of
71 patients with history of cerebral vascular occlusive disease. Further, the incidence of middle
cerebral branch occlusion associated with either
irregular or ulcerative lesions of the extracranial
carotid arteries was 3 3 % , compared to 16% of
patients with angiographically "normal" or smoothly

stenosed extracranial carotid arteries. More and
more evidence, therefore, implicates the process of
arterial-arterial embolization as a major one, particularly in transient and often in persistent focal
cerebral ischemia.
Thus we have a process of arterial-arterial
embolization as distinct from cardiac-cerebral artery
embolization, which apears to be a major pathogenic factor in ischemic strokes toward which treatment should be aimed before the stroke occurs,
when we are warned by the presence of a transient
episode. Since the term embolus is overextended
and usually implies cardiac source, muddying our
thinking about cerebral ischemia, I have long felt
that to require the term "cerebral embolus" to include in its embrace the widespread process of arterial embolization would be like asking a mouse
to extend its amorous interests to an elephant; it
would confound confusion where too much confusion already exists. I have proposed, therefore,
the acronym, "artarem,'' to describe an embolus
which arises in an artery (art-) and lodges in a
distal artery ( -ar-) by a process of embolization
(-em). The process can be described as being
artaremic. On the other hand, if the embolus, from
clinical evidence, appears to arise from the heart,
the term "cardiarem" will serve, and the process of
heart-to-artery embolization might be described as
"cardiaremic." Adjectival modifiers such as cerebral
fibrinoplatelet artarem or myxomatous cerebral cardiarem could give rise to further diagnostic precision.
Having noted angiographic and operative evidence of the artaremic process, research began for
a safe medication which could delay or inhibit the
first step in fibrinoplatelet emboli. Surgical studies had
already clearly revealed that the neck lesion often
was related to visual and cerebral symptoms since
these symptoms disappeared after surgery, whereas
control patients who were not surgically treated with
known similar lesions often developed stroke or
permanent visual defect. The experience of the
Cooperative Study of Extracranial Arterial Occlusion showed a tenfold reduction in the appearance
of frank stroke in the territory of ·the operated
artery in the neck. There can be no doubt, therefore,
that the source of the patient's difficulty was most
often in the prominent lesion at the carotid bifurcation. Surgery, however, has its drawbacks and random studies of surgery have failed to precisely define
the role of arterial surgery.
Our own NYU random study reveals one rea-
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son for the confusion. In patients who were not
randomized, the nonsurgical patients showed a considerably smaller initial long-term survival than the
surgical patients, suggesting a significant measure
of surgical selection. Where the patients were randomized, long~term survival was equal in · both
groups; initial surgical mortality, however, was significantly greater.
Our figures show that in patients with full
recovery from transient cerebral ischemic attacks,
surgical mortality is down to 3% and long-term·
survival is greater than in the nonsurgical group
(numbers too small for statistical significance) .
Transient ischemic attacks in patients with incomplete recovery are characterized by a greater degree
of surgical mortality; but in the proportion surviving, a larger percentage survived five years. The
other major point of the surgical study was that
in patients with completed stroke, surgical mortality
is prohibitive, particularly in patients who are obtunded , and long-term survival is significantly better
in the nonsurgical group. Mortality over the long
term, however, is not simply a function of cerebral
vascular disease. Associated atherosclerotic disease
is characteristic of this group of patients. While the
major cause of death in the postoperative period
after surgery is stroke, over the long tetm, cardiac
causes account for as many deaths as stroke, and
the number of deaths in the surgical and the nonsurgical series approach one another.
Since stroke surgery is prophylactic, the major
question remains-will stroke surgery in selected
patients significantly diminish the proportion of
stroke and significantly improve survival? No data
from randomized studies have yet settled this issue
completely satisfactorily. Thus, the search has gone
on for safe medications which will depress the tendency for fibrinoplatelet emboli to form on ulcerated
or irregular plaques. Obviously nothing can be done
for the initial process of disehgorgement of gummatous and cholesterol material from the broken
down plaque. Anticoagulants have proven to be
successful in depressing the number of transient
ischemic episodes; however, anticoagulants can be
given only to a reliable, stable patient population,
and such therapy would be much more successful
in Rochester, Minnesota for Dr. Millikan's and Dr.
Whisnaqt's patients than for our patients at Bellevue
Hospital.
In the 1960's, Frasier Mustard's group in
Canada (1 , 2) noted inhibition of the platelet
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aggregation release reaction by sulfinpyrazone. Subsequent studies have shown that anti-inflammatory
drugs, such as butazoladine derivatives and aspirin,
the pyridopyramidine compounds such as Persantine® and the tricyclic antidepressant drugs, have
an effect on platelets. The most profound inhibition
of ADP or collagen-induced platelet (\ggregation
is shown by aspirin. In the in vitro studies, 37% of
serotonin is released with no aspirin, as compared
to no release with aspirin. A tenfold increase in
ADP reveals that aspirin can no longer be effective
against aggregation, but that there is continuing
inhibition of serotonin release. Similarly, aspirin
inhibits connective tissue induced aggregation as
well as serotonin release from platelets. This effect
of aspirin is not confined only to the test tube, but
it has been shown in dogs that arterial thrombus
is retarded when the intimal surf(\ce of an artery
is mechanically or chemically damaged and similar
results have been shown after endarterectomy in
patients receiving aspirin ( 3). While it is known
that as little as 5 gr of aspirin may depress the
aggregation release reaction for as long as five days
in man, as judged by the epinephrine challenge to
platelet rich plasma as well as with most in vitro
tests, this association of inhibition of aggregation
is not clearly related to observed inhibition of transient ischemic episodes. It has been noted, however,
that aspirin will stop transient retinal ischemic attacks, amaurosis fugax. We have been able to follow
a most instructive patient at NYU who had as many
as nine attacks daily of amaurosis fugax , with response to increasing doses of aspirin in terms of
attacks and effect on platelet aggregation release
reaction. This unusual patient demonstrated that
the optimal dose of aspirin for amaurosis fugax
appears to be 5 gr qid. A retrospective study recently
published in Stroke by Dy ken ( 3) shows a relative
diminution of transient cerebral ischemic attacks
in aspirin-treated patients. It is of interest that in
some of his cases the attacks responded better to
four aspirin tablets per day than to two, Prospective
studies of aspirin, directed toward not only the
question of aspirin inhibition of transient attacks,
but also to the more important question of prophylaxis against completed stroke, are in process in
the United States and in Canada and no definitive
statement will be made on this subject for at least
another year.
The judicious mixture of surgical therapy and
prophylactic therapy with a safe platelet antiag-
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gregant appears at this time to be the best combination of approaches to the axiom: the best time to
treat a stroke is before it happeris.

2. SMYTHE HA, OGRYZLO MA, MURPHY EA, MUSTARD
JF: The effect of sulfinpyrazone (ahturan) on platelet
economy and blood coagulation in man. Can Med Assoc
I 92 :818, 1965.
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Cerebral Blood Flow Studies in Stroke*
JOHN STIRLING MEYER, M.D.
Professor and Chairman, Department of Neurology, Baylor College
of Medicine, Houston, Texas

I will discuss here some work we are doing
in our laboratory on the measurement of cerebral
blood flow (CBF). We are using the gamma camera,
which is connected to a computer, to measure
regional CBF. We inject 133 Xe into the carotid
artery and, by using multiple probes, measure the
clearance from multiple regions of the head. The
adv.antage of the gamma camera is that it has excellent resolution and has common probe characteristics. It may be thought of in terms of multiple
probes, although it has a single crystal, and it
acbieves the desirability of multiple regional CBF
recordings confined essentially to one hemisphere bequse of the depth characteristics of the collimation.
The formula for height-over-area analysis in
the clearance for fast and slow flow (or the first and
second slopes of the curve, Fl and F2) is handled
by the computer which gives an automatic write-out.
ln addition, having injected the xenon, which washes
out fairly rapidly over an interval of 12 minutes,
we then inject with a nondiffusable isotope, technetium. By use of a different formula, this gjves
us the regional cerebral blood volume, so that in
the same patient, we have both the regional cerebral
blood flow and the regional cerebral blood volume
on the computer write-out. T able 1 is a typical
record that comes out of the automatic print-out;
it has the advantage of being rapid, taking place
while the patient is being examined. It comes out
objectively with a minimum amount of error, the
program being highly reliable, and gives you both the
regional cerebral blood flow (ROI) and the inean
hemispheric flow (RCBF "H/ A" ) , which is in good
agreement with hydrogen clearance using an entirely
different methodology, as well as the standard

* This is an edited transcription of a lecture presented
by Dr. Meyer, F ebruary 7, 1974, at the Medical College
of Virginia, Richmond.
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deviation. It gives you the fast or so-called gray
flow (FQ) , the white flow (FW), the so-called
weight of gray matter (WG), the weight of white
matter (WW), a regional flow calculated by another method (RCBF "LOG") , and the regional
cerebral blood volume (RCBF) , which is of considerable use because, knowing blood flow, blood
volume, and cerebrospinal fluid pressure, you can
say a great deal about the amount of blood and
parenchyma present in the region under study and
about the various pressure-tissue-flow relationships.
For our 111etabolic studies, we feel that it is less
traumatic and highly reliable to pass the catheter
up into the lateral sinus via the brachia! vein ; thi.s
is done under visualization of the fluoroscope in
the cardiac catheterization laboratory. I say it is
highly reliable, because one can inject a little dye
at the time of placement of the catheter, from which
much can be learned. About 20% of patients have
abnormalities of the venous system, and there is
no question that, with the blind puncture or modificatio~s of it, the needle often finishes up sampling
blood that was certainly not coming from the brain,
whjch accounts for some of the errors in methods.
To summarize some of the data-it will be
found that the earlier the patient is studied after
a stroke, the greater is the reduction of CBF. I
would like to point out that CBF is reduced not
only on the diseased side but also on the healthy
side (Table 2) . We called it diaschisis and supposed
that it was due to the release, following stroke,
bilaterally or perhaps from the brain stem, of some
neurotransmitter, and it was suggested that it might
pe serotonin or some related substance. Judging
from pur current studies, it now appears that indeed
there are neurotransmitter
releases in a unilateral
.
.
stroke and that these neurotransmitters, bilaterally,
include norepinephrine, serotonin, and C-AMP;
these reduce cerebral blood flow and decrease me123
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TABLE I
REGIONAL CEREBRAL BLOOD FLOW MEASUREMENTS USING GAMMA CAMERA
AND lNTERTECHNIQUE COMPUTER SYSTEM
ROI

RCBF"H/A"

1,4
2,3
2,4
2,5
2,6
3,3
3,4
3,5
3,6
4;3
4,4
4,5
4,6
5,4
5,5
6,4
6,5
MEAN
$.D.

42.2
35.2
33.7
32.5
32.0
32.2
32.5
27.6
26.8
35.4
35.4
37.I
23.9
26.9
24.6
19.4
22.1
30.0
5.7

Typical Print-Out of RCBF Data
FG
WG
FW
WW
41. 57
48.93
43.88
37.52
33.69
46.13
41.98
38.04
50.74
53.48
52.30
51.31
31.24
49.68
59.84
30.68
33.82
41.87
13.04

65 . 1
38.2
46.3
49.1
61.0
47.8
49.5
34.3
35.5
30. 3
44.3
33.0
29.9
29.0
10.7
25.I
43.5
39.5
13.0

14.81
28.27
19.70
18.96
16.27
19.62
17.73
19.81
25.35
30.26
25.99
19.81
25.84
23.76
28.68
17.24
40.35
23.08
6.27

34.9
61.8
53.7
50.9
39.0
52.2
50.5
65.7
64.5
69 . 7
55.7
67.0
70.1
71.0
89.3
74.9
56.5
60.5
13.0

RCBF"LOG"

RCBV

32.2
36.2
30.9
28.I
26.9
32.3
29.7
26. I
34. 3
37.3
37.6
30.2
27.5
31. 3
32.0
20.6
23 . 2
30. 4
4.6

9.62
8.95
7.58
6.29
6.09
8.30
6.49
5 . 59
5.21
7.36
6 . 37
4.90
4.77

5.59
4.50
4.05
4.15
6.22
I. 61

Radioisotope: 133Xe
Diagnosis: Acute subarachnoid hemorrhage due to rupture of basilar artery aneurysm, diffuse vasospasm, and acute
hydrocephalus

TABLE 2
HEMISPHERIC BLOOD FLOW AND METABOLIC INDEXES
IN A SERIES OF PATIENTS WITH ACUTE UNILATERAL CEREBRAL lSCHEMIA
Diseased Side

Healthy Side
HBF
(ml / 100 gm
HMI0 ,
(ml / 100 gm
HMico,
(ml / 100 gm
HMiar
(ml / 100 gm
HG:O
(ml / 100 gin

HRQ
Values =
N =
P =
HBF =
HMI0 , =
HMico, =
HMI01 =
HG:O =
HRQ =

brain/ min)

34.6 ± 3.4 (N = 30)
f--- - - - --u.01
2.28 ± 0.42 (N = 25)

<

p

<

32. 4 ± 3.3 (N = 32)
0 . 02- -- - - ----<
2.07 ± 0.45 (N = 31)

brain/ !llin)
1.84 ± 0.52 (N

=

1.88 ± 0.48 (N

24)

=

31)

brain/min)
brain / min)

3. 54 ± I. 17 (N = 25)
f - - - - - - - -10 . 02
I. 58 ± 0. 54 (N = 25)

<

0.80±0.17(N = 24)
1 - - - - -- - -10.02

< p < 0.05- - - - - ----<

p

<

2. 87 ± I. 02 (N = 30)
0.05---------<
I. 46 ± 0. 63 (N = 30)

brain/ min)

mean ± standard deviation
number of cases
t test values
llemispheric blood flow
hemispheric oxygen consumption
hemispheric carbon dioxide production
hemispheric cpnsumption of glucose
hemispheric glucose:oxygen utilization ratio
hemispheric respiratory quotient

0.92±0.23(N

=

31)
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tabolism bilaterally, despite the fact that one has
only a unilateral stroke (Fig. 1).
One notices that with the passage of time, CBF
improves and after about three weeks, the flow in
the nonischemic hemisphere returns to normal. The
quantitative reduction inflow also correlates with
the size of the infarct, as assessed clinically, as well
as with the degree of EEG change, particularly if
it is a cortical infarct; the correlation is a little more
difficult if it is a subcortical infarct. There are correlations, to some extent, with other assessments of the
degree of involvement such as of the brain stem. Bilateral reduction of oxygen and glucose consumption
and C0 2 production are noted, as well as blood flow
reduction, although there is a greater reduction on
the diseased side than on the healthy side, the respiratory quotient (RQ) is normal.
It should be noted that a hemisphere having
a major infarct with hemiplegia still consumes appreciable oxygen-more than one would think, considering the neurological deficit. Also, abnormal metabolism was occurring on both sides (Table 3).
There was a release of free fatty acids and inorganic
phosphate, as well as serotonin and norepinephrine,
from the infarcted brain; this has now been confirmed from cerebrospinal fluid. Inorganic phosphate
from the infarcted brain appears only in the first
14 days of stroke and tends, with the recovery
process, to revert to no essential A-V difference.
I want to mention a little about studies with
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the use of intravenous glycerol and its effects on
CBF and metabolism. We are interested in glycerol
because not only did it bring about a significant
reduction in intracranial pressure in our stroke
patients, after intravenous treatment, but the patients also showed a significant clinical improvement. We were unable to show this with mannitol
and, for this reason, think that perhaps glycerol
had some metabolic benefits along with its hyperosmolar effect. It is a very nice investigative tool
for manipulating the cerebral metabolism as well.
An infusion of glycerol increases cerebral blood
flow, but (and this was a big surprise to us) it
decreases the oxygen consumption. We have 30
more patients now and this has become highly significant. The C0 2 production also goes down, and
the glucose consumption (in a mixed group of
pa~ients) has a tendency to increase, which was

TABLE 3
HEMISPHERIC METABOLISM IN ACUTE UNILATERAL CEREBRAL IscHEMIA

Arterial
Concentration
/3-Hydroxybutyrate
(mg/di)
Glutamate
(mg/ di)
Triglyceride
(mg / di)
Free Fatty Acid
(mM/L)
Inorganic
Phosphate
(mg/ di)
Serotonin
(µg / dl)

4 . 36±4.47(N = 13)
3.98 ± 2.21 (N = 9)
87.5 ± 38.5(N

=

13)

Arteriocerebral Venous Difference
Healthy Side
Diseased Side

Concentration
in CSP

+I.04±0.73*(N = 6) +0 .27±0.32*(N = 13)
t--- - --0 . 001 < p < 0 . ()()5,-- -- - ;
+0.25 ± 0.25* (N = 7) +0.21 ± 0.15 (N = 8)

N.E.

+I.3 ± 10.6(N

= 9)

+I.5 ± 7.0 (N

=

13)

N.E.
N.E.

1.153 ± 1. 765 (N = 8) +0.121 ± 0.237 (N = 5) -0.208 ± 0.217* (N = 8)

N.E.

2. 34 ± 0.49 (N = 14)

N.E.

12.48 ± 4.35 (N

=

18)

-0.13 ± 0 . 23 (N = 6)

-0.15 ± 0.12* (N = 14)

1.92 ± 3.19(N = 12) -0 . 23 ± l.92(N = 18)
i---- - --iO. 02 < P < 0. 05*- - -- -l

* = statistically significant difference from normal
Values = mean ± standard deviation
N = number of cases
N.E. = not examined

6.10 ± 4.86* (N

18)
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EF FECT OF IV GLYC ER OL ON rCBF

STEADY STATE
PoCOz _38

AFTER 500ml of Glycerol

A CASE OF ACUTE CER EBRAL I NFARCTION

HBF • 33.8 ml/IOOgmlmin

HB F = 36 .8 ml/IOOgm/ min

PoC02 36.5

significant in diabetics and insignificant in nondiabetics. We have postulated that we were improving metabolism other than the usual oxidative
metabolism; possibly, we were recoupling uncoupled
oxidative metabolism. We also considered that
glycerol may provide another source of energy, which
may tend to improve cerebral energy production as
well as the membrane integrity and function. The
EEG improves regularly and the improvement appears within two hours during continuous recording.
There is an increase in central venous pressure, as
might be anticipated, due to the hyperosmolar effect
of an infusion of 500 cc of a substance that is
drawing fluid into the circulating blood volume. Since
the intracranial venous pressure is a mean between
the central venous pressure and the cerebrospinal
fluid (CSF) pressure, then essentially, there is an
increase followed by a decrease in the intracranial
venous pressure. The mean arterial pressure is increased also by a substance that increases a circulating blood volume. Regional CBF and blood
volume studies. of the effects of glycerol on the
ischemic area of the middle cerebral artery occlusion show redistribution of blood with an increase
in blood flow and blood volume in the infarcted
zone (Fig. 2) . Often, if there is a marked hyperemia
on the border zone, there is a redistribution of blood
in the infarcted zone, with reduction on the bordering
zone. The mean hemispheric flow goes up regularly.
Our data show a significant reduction, after the use
of glycerol, in the release of free fatty acids and/ or
inorganic phosphates from the infarcted brain. We
believe that glycerol is combining with free fatty

acids to form triglycerides. Inorganic phosphate may
be taken up by ADP to fo rm ATP. It could also
be that the phospholipids are being resynthesized.
Norepinephrine and serotonin in the CSF of
patients with acute stroke are elevated ; it seemed
likely that, in cerebral ischemia, the reduced tissue
P 02 might be interfering with the synthesis of
neurotransmitters, such as norepinephrine and serotonin and that the release of these might interfere
with neuronal function . We measured C-AMP in
the cerebrospinal fluid of these patients and found
that it was significantly increased, actually much
more significantly than serotonin and norepinephrine.
If these neurotransmitters were disordered in the
brain and were causing trouble, we wondered
whether, with the use of adrenergic blockades such
as propranolol or phenoxybenzamine, one could
show an effect similar to that of glycerol, and
indeed, this is what happened . The introduction of
propranolol shows the same reduction of oxygen
consumption, C0 2 production, and glucose utilization. This reaction makes sense because norepinephrine is known to stimulate glycolysis and oxidative
consumption and has been shown to be released
in infarcted brain and to stimulate the release of
free fatty acid. This finding supported our view
that the release of these neurotransmitters is very
important in cerebral infarction and may enhance
the symptoms. We found also that the release of
fatty acids was improved by the infusion of propranolol, which makes sense because norepinephrine
stimulates the release of free fatty acids from fat
stores and lipids. Inorganic phosphate, likewise,
tended to be reduced and the consumption of triglyceride, increased. Phenoxybenzamine, which is
another a-adrenergic blocker and blocks serotonin
as well as norepinephrine without having any effect
whatsoever on hemispheric blood flow, reduced oxygen consumption and C02 production in the same
pattern that we found with both propranolol and
glycerol. The use of phenoxybenzamine tended to
reduce the release of free fatty acids and enhance
the uptake of inorganic phosphate and triglycerides
by the brain.
After about the 14th day, the serotonin disappears, as does the C-AMP, from the cerebrospinal
fluid in patients with acute cerebral infarction; the
serotonin change can be correlated with the cerebral
blood flow . As the serotonin disappears , CBF increases, which supports the view that serotonin is
important in diaschisis and the bilateral reduction
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of CBF. Other vasoconstrictive substances, such as
epinephrine or norepinephrine, angiotensin, or
prostaglandins may exist, which we have not measured yet.
C-AMP is the second messenger for virtually
all the neurotransmitters of the central nervous system, certainly for serotonin and norepinephrine.
We found that there was similar elevation of CAMP in cerebral venous blood when compared
to the arterial blood in the steady state before
glycerol. After giving glycerol, there was a reduction in the cerebral venous C-AMP, an inhibition of
the release of C-AMP from the infarcted brain.
An elevation of C-AMP in the steady state was
noted in the cerebrospinal fluid of patients with
cerebral infarction as well. When glycerol is given
intravenously, there is a reduction of the C-AMP
in the cerebrospinal fluid .
This consideration of the relationship of neurotransmitters not only to cerebral infarction but also
to subarachnoid hemorrhage is, to my mind, the
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most promising area of investigation over the next
decade. There is also a quantity of evidence that
neurotransmitters play a large part in spasm following subarachnoid hemorrhage and in the disturbance of neurological function in that situation.
Following subarachnoid hemorrhage, some remediable medical problems arise. Apart from clipping
of the aneurysm, which the neurosurgeons are able
to do, there is the problem of communicating hydrocephalus, which is extremely common in about
40% of patients. It can be discerned by the method
of determining regional CBF and doing a spinal
tap. If you note an increase in cerebral blood flow
with removal of 25 cc of spinal fluid, you know
you have a problem with communicating hydrocephalus. This is because autoregulation is disturbed.
This increase will not occur when a spinal tap is
done on a normal person who does not have communicating hydrocephalus. Finally, one can give
glycerol and reduce the brain edema in patients
with subarachnoid hemorrhage and brain swelling.

Advances in the Surgical Treatment of Patients with
Extracranial Cerebral Vascular Disease* **
THORALF M. SUNDT, JR., M.D.
Associate Professor of Neurosurgery, Mayo Medical School,
University of Minnesota, Rochester

Introduction. Since the subject of surgery for
carotid artery occlusive disease is too broad to be
covered in its entirety, we will dwell primarily on
some results of cerebral blood flow measurements
and electroencephalograms performed during this
procedure, their meaning and relationship to states
of cerebral ischemia, and some controversial aspects
of the surgery. An understanding of cerebral hemodynamics and the tolerance of neural tissue to
ischemia is of major importance to any surgeon
or physician dealing with this illness.
Cerebral Blood Flow Measurements during
Carotid Endarterectomy. Cerebral blood flow (CBF)
measurements, determined from intra-arterially injected 133Xe have been performed routinely on all
patients on the author's service undergoing carotid
endarterectomy over the past four years, and therefore, flow data are available from 279 cases of
carotid stenosis and 13 cases of carotid occlusion.
These measurements have been. determined prior
to carotid occlusion, during occlusion, with a shunt
in place (when used), and following restoration of
flow. Analyses of results of these measurements have
indicated an increase in CBF, determined by the
initial slope technique from 58-73 m]/100 gm/min
when carotid artery stenosis exceeds 90% ( 1) . When
carotid artery stenosis is less than 90%, analysis
of these measurements has indicated no essential

* Presented by Dr. Sundt at the 27th Annual Stoneburner Lecture Series, February 7, 1974, at the Medical
College of Virginia, Richmond.
** From the Cerebrovascular Clinical Research Center and the Department of Neurologic Surgery, Mayo Clinic
and Mayo Foundation, Rochester, Minnesota 55901; this
investigation was supported in part by Research Grant NS
6663 from the National Institutes of Health, Public Health
Service.
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change in CBF. These measurements have been
recorded with the patient under general halothane
anesthesia with moderate induced hypertension and
with a constant Paco, of 42 torr. Therefore, these
anesthetic CBF measurements are higher than those
found in normal awake patients, where a normal
CBF approximates 54 m]/100 gm/ min. I do not
wish to imply that an increase of CBF in this
setting, of this magnitude, is necessarily lasting or
of clinical significance other than an area's susceptibility to symptomatic emboli.
It is necessary to distinguish between the change
in absolute regional CBF and alteration in relative
contribution to that flow from the internal carotid
artery before and after endarterectomy. Even in
instances where no true alteration in CBF could
be determined by these types of measurements,
Boysen (2) found an increase in internal carotid
artery flow following endarterectomy, and therefore an increase in the relative contribution to CBF
from the vessel operated upon, when a significant
stenosis was present.
Electroencephalographic Measurements during
Carotid Surgery. In addition to CBF measurements,
all patients undergoing endarterectomy now have
a constant electroencephalogram (EEG) recorded
from the time of induction-of-to-arousal-from anesthesia. It has been found that the EEG is a valuable
monitor for evaluating cerebral function during this
surgery with a properly maintained level of anesthesia (3). It is noninvasive, has no risk, and has
proven to be highly accurate in correlating cerebral
metabolic function during surgery with the neurological function postoperatively. The EEG offers a
continuous technique for monitoring cerebral function throughout the entire procedure, something
that is not possible by any other technique unless
MCV QUARTERLY 10(3): 128-133, 1974
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the patient is operated upon under local anesthesia.
The very close correlation between the EEG and
the CBF measurements below 17-18 ml/ 100 gm/
min at a Paco, of 40 torr is most impressive. In
our series to date, we have not had a single CBF
measurement during carotid occlusion below this
level that did not have an associated EEG abnormality. The lower the occlusion flow, the more
rapid the EEG changes. A typical EEG demonstrating the changes with occlusion and resolution with
a shunt in place is illustrated in Figure 1.
CBF-Ischemic Tolerance Ratio. The ischemic
tolerance of neural tissue is directly proportional
to the relative decrease in CBF. A decrease in CBF
to between 20 and 30 ml/ 100 gm/ min can be tolerated quite well for limited periods of time. When
the CBF falls to below 18 ml/ 100 gm/ min, cerebral
metabolic function changes and a physiological paralysis follows (1 , 3). This is, however, to be distinguished from infarction. It is probable that this
degree of ischemia can be tolerated for a period
of hours, rather than minutes, without major infarction, whereas flow reductions below 10 ml/ 100 gm/
min produce infarction in a much shorter time.
This hypothesis cannot be tested in its entirety
clinically, but it has been extensively investigated
in the laboratory. In squirrel monkeys, a degree of
ischemia approximating 20 ml/ 100 gm/ min can
be tolerated for up to two hours without the uniform
development of a cerebral infarction ( 4). In these animals cerebral adenosine triphosphate (ATP) falls
to 55% of normal and cerebral lactate rises to seven
times normal following two hours of occlusion ( 5).
During the period of occlusion, the EEG shows
changes similar to those seen in patients with severe
flow reductions during carotid occlusion. Following
restoration of flow in the laboratory preparation,
there is a gradual rise in ATP, fall in lactate, and
normalization of the EEG. Ah infarction is not
uniformly seen in this animal unless occlusion is
maintained for fout hours . The degree of ischemia
and metabolic alteration which follows this single
major vessel occlusion must be distinguished from
the situation which follows cardiac arrest when there
is zero blood flow. In this setting, ATP falls to 25 %
of normal in only four minutes, and there is the
rapid production of cerebral infarction with the
probability of the "no-reflow phenomenon" ( 6).
We had previously doubted the necessity for
a shunt in any case undergoing carotid endarterectomy, on the basis that flow values seldom if ever
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Fig. 1-A typical EEG demonstrating the changes seen
with occlusion for endarterectomy when cerebral blood
flow falls to 10 ml/100 gm/ min. Changes include both
generalized slowing and loss of background activity. In
this patient with opposite carotid artery occlusion, the
changes were seen bilaterally. Most commonly, changes
occur only on the side of occlusion. The EEG improves
following placement of tl)e shunt and improvement in CBF
values doubles that seen prior to occlusion. (Reprinted by
permission from J N eurosurg 41:315, 1974.)

fell to extremely low levels (7) . it is now apparent
that this hypothesis was incorrect and that, indeed,
a great many patients have CBF measurements with
unilateral carotid artery occlusion that fall to appallingly low levels, and in sorrie instances, to values
too low to measure, approximating cardiac arrest.
Furthermore, unfortunately, we have found that the
degree of backflow is proportional to the cerebral
vascular resistance which varies quite a bit from
one patient to another; that is, it is an unreliable
indicator of CBF and collateral flow. In contrast
to our previous position, we now readily agree that
there are definite indications for a shunt during
carotid endarterectomy.
Use of a Shunt during Carotid Endarterectomy.
A shunt has been employed in approximately onethird of the patients operated upon in this series.
EEG changes, along with occlusion values below
the critical perfusion level, occurred in 56 of these
patients; shunts were used in the remaining cases
because of borderline perfusion values that could
conceivably produce a critical perfusion flow in the
internal capsule area, which might be missed both
by a CBF measurement and an EEG change.
Shunts are not used routinely because there
are several disadvantages in using them. A shunt
interferes with a precise endarterectomy, can serve
as a source of emboli when in place, and requires
constriction of the proximal carotid artery in a
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tourniquet fashion, a maneuver that can injure the
vessel wall.
The time for placement of a shunt has varied
a great deal from one patient to another; the speed
of placement has been proportional to the urgency of
its need. When possible, it is desirable to complete
the endarterectomy in the internal carotid artery
prior to placement of the shunt and, thereafter, to
complete the endarterectomy and angioplastic procedure. With the shunt in place, the patient is totally
heparinized, but in addition to having the patient
totally heparinized, the shunts we are using are
impregnated with heparin to avoid or minimize the
possibility of emboli. Using this new type of heparin
coating, provided for us by Battelle Laboratories
of Columbus, Ohio, we have seen no platelet material at the mouth of the shunt following Hs removal.
Prior to this added measure, even with total heparinization of the patient, we routinely fo~nd platelet
material at the mouth of the shunt.
To this date, none of our patients has developed an abnormal EpG with carotid occlusion
that did not revert with prompt placement of a
shunt; however, one patient in the group did develop
EEG alterations with the shunt in place, proven to
be related to microembolism through the shunt, aµd
this patieqt sustained a permanent neurological
deficit. Since that occasion, we have been using only
heparinized shunts and have had no recurrent problems of that nature. This patient represented the
only embolic complication from the group in which
a shunt was employed.
·
CBF, Ischemic Tolerance, and Paco2 • We have
not routinely employed hypercapnia during the period of carotid occlusion. Under halothane general
anesthesia, hypercapnia predisposes to cardiac arrhythmias, giving problems riot justified by proven
beneficial effect. Boysen ( 2) found, during carotid
epdarterectomy, the expected increase in CBF prior
to carotid clamping from hypercapnia as a result of
maximal vasodilatation. With carotid clamping, however, there was a greater relative reduction in CBF
in comparison to the group studied at normocapnia,
and furthermore, a paradoxical reaction was occasionally demonstrated. In this paradoxical reaction,
hypercapnia did not improve regional CBF but rather
resulted in an intracerebral "steal." We have demonstrated this in our patients also and it therefore seems
safe to conclude that hypercapnia cannot be relied
upon invariably to increase regional perfusion in the
areas of severe ischemia.

The use of hypocapnia, to produce a reverse
steal and hence increase cerebral perfusion to areas
of ischemia, has been suggested by Lassen ( 8) ;
however, a careful analysis of their patient group
with proven cerebral ischemia, treated with hypocapnia, indicated no clinical effect from hypocapnia,
although they were able to procjuce a reverse steal
with its use.
Laboratory studies support the clinical findings of
Lassen and his group (9) and have indicated that although a reverse steal can be produced with the use
of hypocapnia, the effect of hypocapnia in areas of
focal ischemia is definitely detrimental. In a group of
animals with focal ischemia in which hypocapnia was
induced, the cerebral ATP was significantly less and
the cerebral lactate significantly higher than corresponding values in hypercapnic and spontaneously
breathing animals. One mlist conclude that the Paco,
should be maintained at as near a normal level as
possible during carotid endarterectomy and that it
should not be raised to produce hypercapnia or lowered to produce hypocapnia.
Surgical a11d Nonsurgical Lesions. I should now
like to refer to some of the clinical and surgical
aspects of this illness. The majority of patients
upon whom we operated in this series have had
a severe stenosis or a deep ulceration at the origin
of the internal carotid artery from the common
carotid artery. Minor degrees of ulceration at the
origin of the internal carotid artery from the cmµmon carotid artery are not considered surgical lesions unless the patient is quite young. It has been
our judgment that such small ulcers frequently heal
spontaneously, and this is supported by a recent
study designed to determine the frequency of strokes
from such lesions. Minor degrees of ulceration or
stenosis at the origin of the internal carotid artery
are not uncommon in the elderly population, and
even when associated with a bruit, are not necessarily an indication for surgery. Loops of the internal carotid artery are rarely symptomatic-notwithstanding a recent report to the contrary.
Correlation of Angiographic Findings with
Symptom Complexes of Carotid Arterial Disease.
A correlation, 'retrospectively, of the angiographic
findings , cerebral blood flow measurements, and
clinical symptomatology in patients suffering from
carotid ulcerative stenosis has permitted a judgment
regarding the etiology of the various forms of symptomatology. In general, the focal symptom complexes are felt to be most commonly the result of
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cerebral embolization (10), but we have noted that
focal regions of the brain, and to a lesser extent
the retina, are particularly vulnerable to emboli
if that region is under a low perfusion pressure; this
is an angiographic finding-space does not permit
us to discuss it in detail. In such instances, regions
of marginal perfusion are dependent in part on
collateral circulation, so that any embolus to a
collateral vessel is likely to be of major significance
symptomatically. Ooviously, such regions of marginal perfusion are also particularly vulnerable to
periods of hypotension. In general, amaurosis fugax,
transient ischemic attacks (TIA's), and small completed infarcts represent manifestations of cerebral
embolization (11). A progressing stroke-that is, a
neurological deficit which is progressive over a period
of hours-quite often is the result of multiple embolization into a region of very marginal perfusion.
The temporal profile of this, type of progressing
stroke must be distinguished from a massive infarction that reaches its zenith two or three days
later from severe cerebral edema. The progressing
stroke which begins with a minor neurological deficit
and progresses through intermittent stages of deterioration can be helped by emergency surgery in
many instances, whereas the massive infarction with
immediate profound ·hemiplegia is often a contraindication to surgery.
Generalized cerebral ischemia represents an
uncommon, nonembolic, symptom complex that may
be the patient's only complaint or may coexist with
symptomatology of focal cerebral ischemia (12). An
individual with generalized cerebral ischemia must be
differentiated from the patient with vertebrobasilar
insufficiency; these patients are suffering from severe
bilateral carotid arterial stenosis or a high-grade
stenosis in association with a contralateral occlusion.
Upon assuming the erect posture, there is a rather
dramatic fall in the retinai artery pressures, although
the peripheral blood pressure does not fall proportionately. At this time, the patient may complaih
of light-headedness or a sensation that he may faint.
This is not true vertigo. He may complain of dimness of vision or difficulty in balance. The family
usually reports changes in behavior or memory.
CBF measurements have indicated a very significant
increase in CBF following endarterectemy in these
patients, and there has been a rather gratifying
improvement following surgery. Approximately 10%
of our patients have had symptomatology of this
type. I would like to reemphasize that these are
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not patients with presenile dementia or vague lightheadedness. In addition to the symptoms, ther~ are
the hard findings of reduced retinal artery pressures,
bilateral or unilateral carotid bruits of a very significant character, and subsequent angiographic
confirmation of the pathology-severe disease-not
kinking or minor irregularities.
It is uncommon that we operate on patients
for the presence of a bruit alone; however, the character of the bruit and other features of the examination, such as the presence or absence of retinal
emboli, the patient's age, and the · presence or absence of vascular disease elsewhere, enter into the
decision regarding the meth()d of treatment.
Preoperative Risk Factors in Carotid Endarterectomy. Space doe~ not permit details of our system
for grading a p;itient's risk for surgery and the
morbidity and mortality related to these risk factors,
which include obesity, advanced age; coronary artery
disease, progressing neurological deficits, frequent
daily transient ischemic attacks, contralateral arterial
occlusion, high bifurcations, long plaques, and soft
thrombi. This system is gracied from I through IV
for carotid stenosis, acute internal carotid occlusion
being considered grade V and analyzed separately.
The combined morbidity and mortality in this series
has ranged from 1% in low-risk, or grade I, patients for surgery to 8 % in high-risk grade IV
patients for surgery ( 12).
Vessel Patency. Patency in all vessels on wtiich
we have operated for ulcerative stenotic disease was
99.3% at the time of discharge from the hospital
as determined by retinal artery ·pressure (RAP)
measurements, angiography, or both; however, foµr
vessels were reopened prior to discharge with insertion of a vein graft because of occlusion in the
immediate period following surgery. All of these
occurred earlier in the group in which grafts were
not employed; all were symptomatic with TIA's;
all occurred in relatively small vessels; and all were
detected or confirmed by finding a reduction in the
RAP which in each case returned to normal after
restoration of flow and patency. In the first patient,
reopening was delayed and a permanent upper
monoparesis and mild expressive aphasia resulted.
In the other three patients, the vessels were immediately reopened, and there was no delay in dis.,
charge from the hospital and no morbidity. One
vessel in a grade IV candidate occluded simultaneously with a myocardial infarction; flow was
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not restored and hemiplegia resulted; this has been
our only permanently occluded artery.
To Patch or Not To Patch. Admittedly one can
perform this surgery without the use of a patch and
have the vessel remain patent in most instances.
There is little question in my mind at this time,
however, that the use of a patch improves the
prognosis for both acute and chronic patency. The
use of a patch prolongs the procedure, but with
careful monitoring, this is of no great importance.
We frequently reinforce the portion of the graft in
the common carotid artery with a thin teflon sheath
to prevent an aneurysmal dilatation and excessive
stress on the graft in patients who are hypertensive.
Hemorrhagic Infarction. The final controversial
subject I would like to discuss is that related to the
risk of hemorrhagic infarction. This risk has led
some surgeons to consider the presence of any
recent neurological deficit and certainly a progressing deficit as a relative contraindication to surgery
(13). The controversy is not easily resolved. Our
group of patients who were neurologically unstable
at the time of surgery, considered as grade IV risks,
embraces a group of 56 patients in whom we have
had ;m 8% combined morbidity and mortality; the
risks of not operating are obviously considerably
higher. This group includes progressing strokes, frequent daily TIA's, impending occlusion with ischemic
carotid pain, and recent minor fixed deficits in
association with severe degrees of ulceration.
Hemorrhagic cerebral infarction can result from
cerebral embolization with or without surgery (14).
A very high ris.\c of surgery in these unstable neurological patients is related to a soft thrombus that
is frequently present at the bifurcation of the carotid
artery and is superimposed upon an ulcerated plaque.
In these patients, extra care must be ~xercised in
preventing a recurrence of cerebral embolization.
It wouid seem likely that hemorrhagic infarction
has often resulted from embolization rather than
restoration of perfusion pressure to an ischemic
region of brain.
The cbmbination of a reduced retinal artery
pressure on the side of intended surgery, and a
major branch occlusion intracranially with a region
of severe ischemia represents, in our judgme,nt, a
contraindication to surgery.
Conclusion. The use of intraoperative CBF
measurements, continuous EEG's, postoperative
RAP's, vein patches, ~nd intraoperative shunting

when indicated, has aided materially in reducing
morbidity and mortality in this surgery.
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Clinical Advances in the Diagnosis of Cerebral
Vascular Disease*
JOHN STIRLING MEYER, M.D.
Professor and Chairman, Department of Neurology, Baylor College
of Medicine, Houston, Texas

I have chosen some thoughts about recent
clinical advances in the diagnosis of cerebral vascular disease, which I feel are appropriate for this
paper, confining my discussion to the signs, symptoms, natural history, and risk factors of cerebral
vascular disease.
Atherosclerosis and stenosis of the cerebral
vessels result in occlusion and embolization of the
brain parenchymatous vessels, particularly if the atherosclerotic lesions of the vessels not only stenose
but cause ulcerated lesions as well, which will give
rise to fibrinoplatelet emboli and even large, red
emboli. This process results in slow blood flow,
turbulence, erythrocyte and platelet aggregationwith local anoxia resulting in endothelial damage,
the loss of plasma fluid-resulting in brain edema,
and compression of capillaries and venules. This
vicious cycle is depicted in Figure 1, showing a
worsening of the ischemic and hemorrhagic infarction. In the area of circulation around the ischemia,
hyperproteinemia and hemoconcentration occur,
which tend to cause deposition of the platelets.
One can easily see these platelets under direct
examination of the microcirculation of the brain,
showing increased viscosity and the tendency toward
thrombosis and further infarction.
Hypertension will promote atherosclerosis, and
certain other systemic factors such as hypotension
or lowered blood pressure, particularly much below
80-90 mm Hg (systolic), will worsen the situation
because of distorted autoregulation. Associated poly-

* This is an edited transcription of a lecture presented
by Dr. Meyer at the 27th Annual Stoneburner Lecture
Series, February 7, 1974, at the Medical College of Virginia, Richmond.
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cythemia or sickle cell disease will be aggravated
by the situation.
Conversely, anticoagulants and platelet inhibitors tend to prevent the aggregation of these
platelets and erythrocytes as well as preventing the
development of thrombosis. Systemic dehydration
will have an adverse effect while collateral blood
flow enhancement will tend to improve the situation. Hyperlipidemia and hyperlipemia will cause
aggravation for several reasons-they promote
atherosclerosis and they enhance the tendency toward platelet aggregation and changes in the properties of the blood. Hypothermia will tend to protect
the patient by decreasing brain metabolism; systemic anoxia will make him worse. Neurotransmitters are released, probably as a result of the
deleterious changes.
Let me summarize the risk factors with which
the American Heart Association Committee concerned itself in 1971 (1) , which we now agree are
reasonably well established (Table 1). A hypertension of 160/ 95 mm Hg is present in at least
85% of cases-a significant risk factor, the control
of which is one of the great advances in prevention
of stroke. EKG abnormalities occur in 60-70% of
our patients with stroke, consisting of left ventricular hypertrophy (LVH), myocardial infarction
(MI), or a recent or old dysrhythmia. Clinical
angina, myocardial infarction, claudication, diminished pulses, bruits-all are associated with a stroke
patient and should be sought. Diabetes mellitus
occurs, depending upon how you evaluate it, in at
least 30-40% of these patients. Certainly, an elevated fasting blood sugar and an abnormal glucose
tolerance test or a two-hour postprandial blood
sugar exceeding 160 mg% should be considered sigMCV QUARTERLY 10(3): 134·138, 1974
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nificant. Recently, we have been studying the blood
lipid profile, another important factor, with Dr.
Gotto at our institution. Type IV lipidemia, particularly, is a risk factor that occurs in approximately 30% of these patients. Other factorssmoking, polycythemia, erythrocytosis, gout, and
hyperuricemia should be evaluated. Of our patients
with cerebral vascular symptoms and extracranial
occlusive disease, 43% had hyperlipoproteinemia,
and almost all of these were type IV. Of our patients with intracranial small and large vessel lesions,
20% had hyperlipoproteinemia, but of those with
intracranial small vessel disease, only 3% had hyperlipoproteinemia. As might be expected, of those with
combined extra- and intracranial lesions, there is
an incidence of 25 % . Those with a normal
angiogram have, essentially, a normal lipoprotein
pattern. In summary, one can say that hyperlipoproteinemia type IV is a significant aspect of extracranial occlusive disease.
It is wise in evaluating your patients, particularly the young patients with hypotension and
extracranial occlusive cerebral vascular disease, to
look for fibromuscular dysplasia. Acute myocardial
infarction is seen in 10% of patients with acute
stroke and in 60% of those with chronic arteriosclerotic heart disease. As illustrated in Table 2, a
stroke-prone individual is one who has not yet had
a stroke but is likely to because of the risk factors
present in his profile. Thus, a patient with hypotension, diabetes, hyperlipidemia, and/ or arteriosclerotic heart disease, who is obese or a heavy
smoker, is extremely apt, on a prospective clinical
trial period, to have a stroke and is at great risk.
Similarly, patients having transient ischemic
attacks (TIA's) or reversible ischemic neurological
deficits (RIND's) will proceed to a stroke 30-50%
of the time within a five-year period. Transient
ischemic attack is a neurological deficit existing,
due to cerebral vascular disease, for 24 hours or
less; whereas reversible ischemic neurological deficit
is a little stroke lasting longer than 24 hours but
with recovery in about three weeks. A patient who
has had a neurological deficit for longer than 24
hours, progressing in the acute stage is said to have
a stroke in evolution. A stabilized neurological
deficit appears in a patient who has a stroke in
the past and comes in sometime later in a stable
condition. Table 3 represents a summary of several
natural history studies of cerebral vascular disease,
which indicates that of those undergoing TIA's,
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one-third progress within five years to irreversible
cerebral infarction; one-third continue to have TIA's
and therefore continue to be at risk of cerebral infarction; and one-third seem to cease having TIA's
spontaneously within five years, without further neurological disorder, but they are at great risk of
suffering other complications of atherosclerosis such
as myocardial infarction.
The mechanism of TIA's is still under consideration by many scientists and physicians. Cer-

TABLE 1
RiSK FACTORS IN STROKE*

1. Hypertension of 160/ 95 mm Hg (present in 85 3 of
cases)
2. Cardiac Enlargement by X-ray
3. EKG Abnormalities, LVH, MI, and Dysrhythmia
4. Clinical Angina, MI, Claudication, Diminished Pulses,
and Bruits
5. Diabetes Mellitus (2 hr pp 160 mg % or more; FBS 120
mg % or more)
6. Elevated Blood Lipids (cholesterol, fl-lipoprotei ns,
triglycerides)
7. Smoking
8. Erythrocytosis
9. Gout-Hyperuricemia

* Reprinted by permission
sociation, Inc. (1)

of the American Heart As-
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TABLE 2

TABLE

CLINICAL CLASSIFICATIONS

R EMEDIAL MECHANISMS IN TRANSIENT lSCHEM!C ATTACKS

1. "Stroke-prone" individual

1. Embolization

2. TIA's and RIND's

2. Cardiac dysrhythmia
3. Transient hypotension

3. Stroke in evolution and patients with moderate-to-

severe neurological deficits still in acute stage
4. Stabilized neurological deficits

tainly, the two major headings are recurrent
fibrinoplatelet emboli and hemodynamic factors.
What are the remediable mechanisms in TIA's
(Table 4)? First of all, there is embolization for
which doctors have advanced treatment. Cardiac
dysrhythmias can cause cerebral vascular symptoms
simply by decreasing cardiac output when the rate
of the heart exceeds 160 or falls below 60. Transient
hypotension can cause cerebral vascular symptoms
as well, particularly if the patient has dysautoregulation or impaired autoregulation of the brain. Hypertension with spasm of cerebral vessels, first described many years ago and then abandoned, is now
well established as a significant factor. Hypoglycemia, a relatively rare factor, can cause localized
neurological deficits but will respond to the administration of glucose. Likewise, polycythemia, the
subclavian innominate steal syndrome, severe anemia, kinking of vessels in the neck, and external
compression may, by such things as osteophytes
and cervical spondylosis, give rise to TIA's.
While it was considered dangerous at one point
to lower elevated blood pressure in patients with
stroke or cerebral vascular symptoms, it now seems
clear that controlling the hypertension improves the
prognosis. In a series of hypertensive stroke patients
treated with Aldomet® for one-to-two weeks, we
noted that cerebral blood flow actually increased as
the mean arterial blood pressure was decreased significantly and thereby decreased cerebral vascular
resistance.
Figure 2 is a sketch of a very important concept

4. Severe hypertension with spasm of cerebral vessels
5. Hypoglycemia
6. Polycythemia
7. Subclavian, innominate steal
8. Severe anemia
9. Kinking of vessels
10. External compression

of how an ulcerated plaque in the carotid artery
can be a source of cerebral embolism. Recurrent
cerebral embolism with recurrent TIA's may occur
in the same distribution repeatedly-a very important warning sign. Thus the ulcerated plaque
may release the embolus which may then lodge
in the middle cerebral artery territory, causing turbulent flow. Circulating fibrinolysin, apparently
present in the body normally but probably decreased
in these patients, tends to dissolve the fibrinoplatelet deposition. Platelet aggregate inhibitors, such as
aspirin, Persantine®, sulfinpyrazone, along with anticoagulants, tend to inhibit emboli. Today, there is
a greater tendency to use platelet inhibitors rather
than anticoagulants.
We studied cerebral embolization in 42 cases
prospectively. In our patients, prosthetic heart valves

Middle cerebnl artery

Anterior cerebral artery

Embolus

I

t

Circulating
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~ ·
TABLE

3

TRANSIENT lSCHEMIC ATTACKS*

1 / 3 -> Irreversible cerebral infarctions
1/ 3 -> Continue to have TIA's
1 / 3 -> Cease in five years

* It is impossible to predict into which category an
individual patient with TIA's will fall.

Turbulent flow
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were important as a source of fibrinoplatelet emboli
to the brain. Rheumatic heart disease may also
cause emboli formation; arteriosclerotic heart disease
may cause emboli as a result of myocardial infarction, pacemaker failure, or dysrhythmias. Carotid
plaques emerge along with cardiac disorders as the
most common causes, accounting for almost all
emboli. There are rare causes such as aortic aneurysms with mural thrombi, carotid stenosis without
ulcerated plaque, carotid kinking, and vertebral
thrombosis. Two types of embolism can result from
the justifiable insertion of prosthetic valves, although
it must be emphasized that 90% or more of patients
receiving them show no complications from their
use, and they should be considered a great advance
in surgical treatment. The fibrinoplatelet emboli that
arise from the valve, particularly if it is a ball valve
with a rough surface, can be seen and can be treated
with Persantine®. The larger types of emboli respond
to anticoagulants.
Although we never used to think that seizures
occurred with cerebral vascular disease, it is now
quite apparent that they commonly occur in cerebral embolization. Neurological findings show that
abnormal tendon jerks· and mo;or deficits are common and cranial nerve involvement is a frequent
physical finding; herrlianopsia is relatively frequent
as well. Regarding the work-up, the arteriogram is
by far the most valuable test and will usually show
the occluded vessel early in the course of disease.
We were able to show the occl~ded vessel in 93%
of our cases. In 90% of cerebrc1I embolisms, the
EEG is abnormal. The brain scan is abnormal in
91 % of the cases and the cerebrospinal fluid (CSF)
pressure is increased in about 50% of the cases
(Table 5). The left hemisphere is involved more
often than the right in cerebral embolisms; the
incidence was about twice as high in our study.
Sixty-five percent of emboli of cardiac origin and
64% of carotid plaque origin lodge in the left hemisphere. This tendency can probably be explained
by the anatomical distribution of the aorta and the
great vessels in the neck. The innominate artery
tends to go against the vector of force or the thrust
of the cardiac output; it is somewhat protected and
emboli would tend to go to the right arm rather
than into the carotid or vertebral artery. The left
common carotid artery, however, is particularly
prone to receive the emboli, since it lies directly
in the direction of the thrust of the cardiac output.
Also, I believe the incidence of plaques is greater
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TABLE 5
Test Performed
Arteriogram
Electroencephalogram
Brain scan
CSF pressure exceeding 180 mm H,O

No. Cases
Studied % Normal % Abnormal

28
30
11

20

7
10

90

9

91

50

50

93

on the left. It could perhaps be argued also that
a patient who is dysphasic and has a left hemisphere
lesion is more likely to be diagnosed, but we rejected
that argument in our own prospective study since
we think we examined all patients very carefully.
In our institution, patients with vertebral basilar
insufficiency have a different type of transient
ischemic attack from patients with carotid emboli;
they tend to have more postural vertigo, dizziness,
photopsia, or homonymous or altitudinal hemianopsia. We feel that is because the process of ischemia
. of the brain stem itself involves those centers that
are concerned with autoregulation. There is evidence
now from many laboratbries showing that autoregulation, the property of the brain enabling it
to maintain a constant blood flow despite changes
in the perfusion pressure, is due, in part, to the
neurogenic innervation; this property has a brain
stem or diencephalic-brain stem origin. Ischemia in
this area will damage the autoregulation process.
A fall in cerebral perfusion pressure will cause a
decrease in cerebral blood flow ( CBF), and the
patient will become dizzy and symptomatic. Data
from analysis of the sites of lesions in acute and
in chronic strokes correlated with the delta CBF
over the delta cerebral perfusion pressure (which
happens to be called · the autoreguiation index)
indicate that the effects are more severe in the
acute stages, especially in those patients with brain
stem and subcortical infarction as compared to patients with cortical infarction. Increased intracranial
pressure is relevant in cerebral infarction.
Cerebral edema can be lethal. We have tried
to combat this with hyperosmolar agents; glycerol
seems to be the best agent that we have evaluated
in cerebral vascular disease. We find that it is better
to treat the patient with 10% glycerol intravenously
for six days rather than four. Glycerol (one should
not use more than 10%) seems to benefit metabolism as well as lower intracranial pressure; it is
another source of energy for the brain.
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Finally, I would like to make a few remarks
about transient global amnesia and dementia as a
result of vertebral basilar insufficiency. Transient
global amnesia and dementia effect persons of middle
age; they have attacks of loss of memory for a period
of 24 hours and then make a more or less complete
recovery. During the attacks, they do not lose personal identity and knowledge of self, but they have
loss of memory for just about everything of recent
occurrence. Tbey are able to carry out routine
behavior; they can respond when spoken to; they
may be rather pale and sweaty. The origin of this
interesting syndrome being uqknown, epilepsy, migraine and various equivalents, and also cerebral
vascular disease were considered as p01~sibilities .
We have studied a fairly large series of these patients,
having followed them now for an interval of twoto-three years. Tbey actually have vertebral basilar
insufficiency wmptoms in addition to tpe attacks
of transient global amnesia. They have drop attacks, ataxia, vertigo and n;msea, vomiting, nystagmus, dizziness, light-headedness, syncope, diplopia,
oscillopsia, paresthesias alternating from side to side,
circumoral paresthesias, tremor, cortical blindness, episodic bilateral blurred vision, occipital
headaches-all of which are symptoms of vertebral
basilar insufficiency. When we analyzed them in
terms of their age, the youngest was 48 years of age
and the oldest was 95 wjth a mean of abo~t 70;
so it is a disease of late-middle-to-·early-elderly aged
individuals. We noted that the cerebral blood flow
measµred in these patients was reduced; the major
reduction W (!S in the occipital area, in the distribu-

tion of the posterior cerebral arteries. We then
analyzeq the patients for the risk factors for cerebral
vascular disease mentioned previously; it is apparent that these patients do have a high incidence
of hypertension, hyperlipidemia, coronary artery
disease of one sort or another, and diabetes mellitus.
A study of their natural histories, prospectively,
indicates that they frequently have had recurrent
attacks of transient global amnesia, often resulting
in dementia; this leads to amnesic stroke with permanent loss of memory and gross dementia in a
vast number of cases. These patients usually have
abnormal EEG's. Bjtemporal EEG's showing occipital slow waves are found most often; occasionally, bifrontal slow waves are seen as well. Angiograms of 12 patients revealed vertebral basilar
arterial disease in the majority of them. Occlusion
or steqosis of the posterior cerebral artery was
extremely common. Thus, clearly, this disease is
due to vertebral basilar insufficiency, and it is probable th at the posterior cerebral artery is responsible
for loss of memory.
I have tried to summarize what I consider to
be recent and, I think, relevant and important clinical findings contributed by neurologists, neurosurgeons, and · internists in the past few years on th e
subject of cerebral vascular disea~e .
REFERENCES
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Reconstructive lntracranial Voscular Surgery*
JOHN M. TEW, JR., M.D., F.A.C.S.
Instructor in Surgery, Division of Neurosurgery, University of
Cincinnati Medical Center; Assistant Director, Neurosurgical
Training Program, Good Samaritan Hospital, Cincinnati, Ohio -

It is scarcely less than two decades since the
initial cautious explorations of reconstructive surgery for the prevention of cerebral infarction caused
by extracranial vascular disease began. The next
years recorded an accumulative experience in the
field of vascular surgery. Early clinical investigations
led to the discovery that extracranial vascular disease
is a major cause of cerebral infarction or stroke.
Estimates indicate, however, that only 30-40% of
the patients with cerebrovascular insufficiency have
significant extracrania:l occlusive disease. For this
larger group of patiertts, previous surgical methods
offer no hope. It is the purpose of this report to
review the current status of our clinical explorations
in the area of reconstructive intracran1al vascular
surgery.
This is not a new venture for as early as 1944,
Henschen ( 1) transplanted a pedicle of temporalis
muscle and artery over the surface of the brain
in a: type of encephalomyosynangiosis. This procedure, performed in a patient with biiateral carotid
stenosis, was similar in concept to the VinebergJ ewett operation for revascula:rization of the myocardium, first published in 1947 (2). The patient
is reported to have improved, but angiographic
confirmation of graft function was not accomplished.
The procedure apparently was not explored further
until the work of Donaghy and Yasargil ( 3) in
1966.
Direct reconstruction of the middle cerebral
artery was successfully performed by Welch ( 4)
in 1956, an amazing feat achieved without the
aid of a surgical microscope and many other refined techniques which today are regarded as essential; subsequent reports by Shililto ( 5), Scheibert
* Presented by Dr. Tew at the 27th Annual Stoneburner Lecture Series, February 7, 1974, at the Medical
College of Virginia, Richmond.
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(6), Drieseh (7), and Chou (8) followed. Jacobson, Donaghy, and colleagues (9) first reported that
the microsurgical technique was of considerable
value in performing this procedure. Subsequently
several centers ( 10, 11) have reported their results
with surgical treatment of occlusions of the middle
cerebral artery. Yasargil (12) tabulated eleven cases
in 1969, of which ,he operated on nine, more than one
week following the onset of symptoms. One case,
on which he operated withirt two hours of occlusion,
failed to improve although t.he artery remained
patent. A second case, on which he operated twelve
hours following occlusion, developed a hemorrhagic
infarction. All cases studied by postoperative angiography were patent.
, In our personal experience, we operated on
only five cases two days-to-two weeks following
occlusion. Patency was reestablished in each case
although, in one case, the embolus had already
passed on to a more distant site. One patient worsened as a result of the procedure probably due to
hemorrhagic infarction and the other four improved,
but their improvement was similar to that expected
in the natural history of this disorder.
Recorde.d ~xperience certainly indicates that
reconstruction of flow through the embolically occluded middle cerebral artery is technically feasible;
yet, experimental evidence indicates that if restoration of flow is to be of value, it must be accomplished in less than four-to-eigbt hours in order
to reverse hypoxia. It must also be remembered
that it is in this period that one incurs the greatest
risk of hemorrhagic infarction if the flow is restored.
Finally, it is rare, indeed, that the patient reaches
the surgeon in the allotted time. In conclusion1 it
seems that this procedure, although technically successful, has few indications in practice. · Hopefully
with the advent of less thrombogenic cardiac valves,
139

140

TEW: RECONSTRUCTIVE INTRACRANIAL VASCULAR SURGERY

What then are the indications for these vascular
augmentation procedures? In a collaborative attempt
to answer this question, investigators from four
centers have pooled a hundred cases for retrospective
analysis ( 16). As a result of this study, the following general indications are suggested:
Generalized Low Perfusion Syndromes
Symptoms:
1. impaireq mentation
2. syncopal episodes
3. transient motor, speech or sensory deficit
4. transient or progressive visual loss
5. ataxia and postural vertigo
Etiology:
1. multiple vessel occlusion
2. multiple stenosis of intracranial vessels
3. unilateral vessel occlusion with inadequate collateral circulation or congenital
anomalies which interfere with collateral
circulation

Fig. I-Preoperative angiogram demonstrates occlusion of
internal carotid artery, collateral circulation through ophthalmic artery, and the course of the superficial temporal
artery (arrows).

the temptation to consider the procedure will disappear.
Having removed the acutely occluded middle
cerebral artery from consideration for reconstruction,
what other lesions and indications for intracranial
vascular reconstruction exist? A recent study from
UCLA (13) indicates that 19% of a series of patients with symptoms of transient cerebral ischemia
had a completely occluded internal carotid artery
as a principle hemodynamic factor in their angiographic study. Other studies (14, 15) indicate that
30-35% of the patients presenting with transient
cerebral ischeinia or mild infarction have obstructive lesions inoperable by general vascular techniques. Accordingly, any effective surgical procedure must either extract the obstructing lesion or
bypass the area of obstruction. Since a major cause
of cerebral insufficiency is unsuspected carotid occlusion, extending from the cervical to the cavernous
portion, extraction of the thrombosis rarely is practical. Bypass procedures then become important in
the creation of compensatory vascular channels.

Lateralized Low Perfusion Syndromes
Symptoms:
1. transient or progressive motor, sensory,
or speech deficit

Fig. 2-Illustration for technique of anastomosis of superficial temporal artery to a cortical branch of the middle
cerebral artery (MCA) .
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Etiology:
1. middle cerebral stenosis or occlusion

with inadequate collateral circulation
2. cervical carotid occlusion or intracranial
carotid occlusion with inadequate circle
of Willis
3. inoperable carotid aneurysms or tumors
such as meningiomas which produce
carotid occlusion
Having agreed on these general indications, a
prospective study is now underway to determine the
merits of this approach to cerebral vascular disease
( 17). This report will be conducted during the next
three years. Presently, I will review with you the techniques currently employed for cerebral vascular reconstruction and the findings in eighteen cases which
have been under my personal care.
Donaghy and Yasargil ( 3) jointly devised the
concept of performing an arterial graft; perhaps they
remembered the initial explorations of Henschen. A
satisfactory superficial temporal artery is required
for this procedure; in this angiogram, a complete occlusion of the internal carotid artery is demonstrated
(Fig. 1, see arrows). Delayed filling is noted through
the ophthalmic and dural communicating arteries.
The illustration (Fig. 2) demonstrates the technique: the superficial artery is dissected free from the
scalp and a small skull flap is turned to expose the
sylvian fissure and a portion of the temporal and
frontal lobes. An oblique end-to-side anastomosis is
created between the temporal artery and a carefully
selected branch of the middle cerebral artery. A segment of the superficial temporal artery is first freed

Fig. 3A-Common carotid angiogram with total occlusion
of internal carotid artery; superficial temporal artery (STA)
has been anastomosed to MCA branch at arrow.

=

Fig. 3B-Later sequence in angiogram (Fig. 3A). 1
site
of STA entrance into cranial cavity and 2
site of anastomosis. Note retrograde reflex toward proximal MCA
trunk.

=

from its muscular branches for 7-8 cm. The artery
remains in situ while the craniotomy flap is turned
and the sylvian fissure is explored. A cortical artery
of 1.5 mm in diameter or greater is selected as it

Fig. 3C-Anterior view of later sequence (Fig. 3A) showing site of anastomosis (arrow) and reflex to proximal
MCA and subsequent filling of distal cortical MCA branches
indicating that the graft is a m ajor source of perfusion
for this isolated hemisphere. Note absence of cross-fill
phenomenon.
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The artery is flushed to remove all air and particles
of thrombus.
This technique has been employed in 14 cases,
there being twelve males and two females with an
average age of 50. Twelve have had symptoms of
transient ischemia, indicating a lateralized low perfusion syndrome. Eight cases have had previous significant cerebral infarctions; two have had symptoms
of progressive dementia indicating generalized low
perfusion syndromes. Angiography demonstrated
that twelve patients had occlusion of the ipsilateral

1.

Fig. 4A- Vein bypass graft. Reversed vein graft is passed
beneath the zygoma and joined to the proximal internal
carotid artery.

leaves the sylvian fissure. Using 20-30 magnification,
the cortical artery is prepared to receive the transplant. Minute penetrating branches are coagulated
and incised. The cortical artery is lifted from the surface of the brain and a slip of latex is placed underneath it. The temporal artery is incised obliquely and
brought into the field. The adventitia and other tissues are stripped from the terminal centimeter of the
temporal vessel. The artery is dilated with pressure
injection of heparinized saline and bathed in a dilute
papaverine solution to reduce spasm. A longitudinal
arteriotomy is made in the thin wall of the middle
cerebral artery branch by a fragment of sharp razor
blade. An incision is made the precise length to accommodate the oblique cut of the temporal artery.
A polyethylene stint, 1.2 mm in diameter, is placed in
the cortical artery after it is irrigated with heparinized
saline. Interrupted sutures of 10.0 monofilament
nylon are placed at either end of the suture line. The
remaining portion is closed with similar interrupted
sutures leaving the final three to be placed. The stint
is then removed and the final sutures are secured.

3.

Fig. 48-Technique for intracranial anastomosis of vein
graft to internal carotid. 1
anterior clinoid excised; note
that clamps exclude ophthalmic and posterior communicating artery collateral supply; 2 = end-to-side anastomosis;
3
completed graft.

=

=
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internal carotid artery; three had bilateral carotid
artery occlusion; five had marked stenosis of the
contralateral internal carotid artery; and three had
unilateral vertebral artery occlusion.
Results. Angiography was performed in all cases,
postoperatively, usually one or two weeks following
the procedure (Fig. 3). Nine grafts were patent; one,
not patent on an earlier angiogram, was opened
when the study was repeated two months later. We
have recognized that spasm may interfere with early
visualization of the graft. Four patients had symptoms of recurrent cerebral ischemia, one of whom
had a patent graft. Two patients who had occluded
grafts have not had recurrent attacks of ischemia.
Both patients with dementia seem improved. Two
patients have had recurrent cerebral infarction; both
had had occluded grafts. One patient suffered a postoperative intracerebral hemorrhage presumably due
to hemorrhagic infarction. One patient died of myocardial infarction. Complications consisted (one case
each) of scalp necrosis, intracranial hemorrhage, sub-
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galeal infection, and myocardial infarction; graft occlusion occurred in five cases.
The results of analyzing my personal cases and
those of my colleagues ( 16) previously mentioned,
suggest that the following contraindications to bypass
graft procedures be considered: 1) major longstanding neurologic deficit; 2) severe recent cerebral
infarction less than six weeks; 3) marked cardiovascular disease; 4) advanced diabetes mellitus; 5) inadequate donor artery-that is, a superficial temporal
artery less than one millimeter in diameter. As noted
in number five, inadequate donor artery has posed a
serious problem in this technique; this inadequacy
was the reason that Lougheed (18), in 1970, suggested the vein bypass procedure. As initially proposed by Lougheed, a saphenous vein graft was taken
from the leg, the valves were stripped, and the small
end was anastomosed to the supraclinoid portion of
the internal carotid artery. The graft was brought out
over the zygomatic arch. We have subsequently revised this procedure somewhat, simply reversing the

Fig. SA, B-Postoperative angiograms of a patient who had generalized low perfusion due to occlusion of all major cerebral vessels. Lateral angiogram demonstrates course of draft (A). Anterior view illustrates bilateral filling of distal circulation (B).
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graft and suturing the larger end to the internal carotid artery (Fig. 4). Flow is restored through this segment as soon as possible, since the hemisphere may
be depesdent on the collateral supply reaching it
through the ophthalmic and posterior communicating
arteries, which must, by necessity, be occluded during the cranial anastomosis. We have not yet developed a satisfactory shunt system to perfuse the hemisphere during the 10-15 minutes required for this
portion of the procedure. Technically, this is a relatively simple procedure; yet the lack of a satisfactory
internal bypass prohibits its performance in some of
the most worthy candidates. The next major obstacle
to bypassing the internal carotid artery is severe
plaque formation in the carotid siphon above the anterior clinoid. Frequently, endarterectomy is required
in opening a segment to receive the vein graft. Impaired runoff may be a problem in spite_of careful
attention to this maneuver.
The artery is led from the cranium beneath the
zygoma into the neck. Prior to completion of the
proximal anastomosis to the common carotid artery,
a large rubber catheter is passed through the graft to
open the valves and fill the vein with heparinized
blood. Our experience with this technique includes
four cases. Three grafts functioned well; however,
one patient, our first, died of a massive hemorrhagic
infarction, although it was six weeks following his
most recent cerebral infarction. Our second patient
suffered delayed thrombosis of the graft, a failure we
believe to be related to compression at the zygomatic
process. A third graft has functioned well for 14
months and the patient remains free of ischemic complications. Figure 5 shows the postoperative angiograms. A fourth graft was unsuccessful due to severe
narrowing of the internal carotid artery. Despite
endarterectomy, satisfactory runoff could not be obtained.
Conclusion. Although our initial experience
with these procedures has certainly been less than
spectacular, it does seem to indicate that further
pursuit of the project of cerebral revascularization is
worthwhile. Careful selection of patients, improvement of surgical technique (including the development of an internal shunt for bypass), and precise
tabulation of results remain essential to the continuation of this study.
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Advances in the Management and Surgical
Treatment of lntracranial Aneurysms***
THORALF M. SUNDT, JR., M.D.
Associate Professor of Neurosurgery, Mayo Medical School,
University of Minnesota, Rochester

Introduction. Patients who have sustained a
spontaneous subarachnoid hemorrhage are victims
of a very serious illness. Not only are they subject at
all tiines to the potentially catastrophic results of a
recurrent bleed, but they are faced with the manifestations of the irritative effects of blood in the subarachnoid space where the blood may function as a
poison to the vessel wall. These acutely ill individuals
may suffer a composite of secondary effects from a
bleed which may include a communicating hydrocephalus, cerebral edema (ischemic or chemically Induced), sterile meningitis, inappropriate ADH syndrome (osmotic effects of blood in the cerebrospinal
fluid), spasm, and the likelihood of a reeurrent bleed.
Physiology and Pathogenesis. Both the physiology and the anatomy of the cerebral blood vessels
differ from those of comparable size elsewhere in the
body ( 1). Unlike most organs and muscles, the brain
maintains a relatively constant blood flow throughout
a wide range of cardiac output and activity. The flow
is approximately 700-900 milliliters per millute,
whether the cardiac output is five liters per minute,
as during rest, or four or five times that volume, as in
strenuous exercise (2). Cerebral blood flow apparently is not directly sensitive to circulating epinephrine or norepinephrine, as these catecholamines do
rtot cross the intact blood-brain barrier (3). Furthermo~e, it is common knowledge that these catechol-
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Service.
146

amines in physiological doses do not produce marked
vasoconstriction, even when applied topically to relatively normal cortical vessels. The cerebral circulation
seems to be governed by its own autoregulation, a
mechanism at present poorly understood ( 4). In
health, this mechanism is not directly sensitive to the
peripheral blood pressure within reasonable extremes.
In cases of acute head injury, subarachnoid hemorrhage or cerebral ischemia, however, the autoregulatory mechanism is no longer functional and cerebral
circulation becomes pressure and volume dependent ( 5).
The presence of a great abundance of autonomic nerves in the conducting vessels in the subarachnoid space has been the subject of recent intensive investigation directed toward identifying a
physiological role for this system. Because conflicting
data are reported from a variety of highly respected
groups, one might maintain almost any role for this
system today artd find laboratory data to substantiate
his position. It is our judgment that the autonomic
nervous system provides a modulating and buffer
action for the conducting vessels in the subarachnoid
space, and we will direct our attention to this aspect
of the problem a little later in this discussion.
Intracranial vessels have a characteristic and
unique design ( 1). Perhaps this is because vessels
inside the head are protected by a rigid skull and are
not subject to the moving stresses and angulations of
vessels in the body. They have a thin intima and adventitia. The media is also quite thin and riot heavily
endowed with elastic tissue. There is, however, a
thick internal elastic membrane of considerable importance in providing the wall with strength. Defects
in the media occur so frequently that they can hardly
be termed pathological.
MCV QUARTERLY 10(3): 146·151, 1974
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Quite different, however, is the occurrence of
defects in the internal elastic membrane. When this
membrane fragments and bulges through a defect in
the media, an aneurysm forms. Controversy continues over the cause of this fragmentation-whether
it is congenital or degenerative-and also over the
importance of a preexisting medial defect. The point
of ·importance concerning the necessity and technique for repair is that the elastic lamella ceases to
exist in the aneurysm itself. Furthermore, as tpe
aneurysm grows in size, although there is no increase
in the pressure per unit of area, the total force on
the aneurysm increases. This subjects the base of the
aneurysm to increased tension anq tends to cause
progressive growth of the lesion.
The weakest points in an aneurysm are usually
in the dome itself or at its base where it arises ·from
the vessel. The wall consists of collagenous tissue,
which is continuous with the adventitia and intima
of the parent vessel. There is a marked difference in
the thickness from one aneurysm to another. Frequently through the operating microscope one can
actually see the blood swirling in eddying currents
through the walls of a thin aneurysm. In other instances, the aneurysmal wall does not seem different
in consistency or thickness from the parent vessel; in
the special case of giant aneurysms, the wall is quite
thick. There is, of course, no way to predict from
arteriography alone what the case is in each patient.
In those patients who survive a subarachnoid hemorrhage from an aneurysm, a blood clot forms around
the aneurysmal membrane, and along with the surrounding arachnoid , seals the vessel ternporarily.
Surgery of Aneurysms. Most surgery for aneurysms today is performed through the operating rnicroscope. A description of the procedure for repair
of an aneurysm might be of interest to those of you
who are not surgeons.
We will discuss four aneurysms, two internal
carotid artery aneurysms and two anterior communicating artery aneurysms, the location of most
aneurysms l!pon which we operate. Space does not
permit us to cover middle cerebral and basilar aneurysms; their appearance is not greatly different.
The first case is of a left internal carotid artery
aneurysm. Looking through the microscope, you expose the operative field, revealing the white structure
of the optic nerve. Initially, with the point of an
eleven blade knife, the arachnoid overlying the optic
nerve is severed and the dissection is carried laterally
to identify the internal carotid artery, the aneurysm
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arising and projecting later(!lly from that structure.
(We prefer the tip of an eleven blade knife to a predesigned surgical instrument for this purpqse; we
have used the latter and found that they dull all too
rapidly; the # 11 blade can easily be replaced with a
new, sharp blade.) There is a noticeable difference
in the texture of the wall of the aneurysm and the
carotid artery. The carotid artery is whitish by comparison to the aneurysm. A cari:;ful look at the
aneurysm should permit you to see that the blood is
swirling in eddying currents through the very thinwalled lesion. The clip we would use to repair this
aneurysm is known (!S a clip-graft; in this case it
would be applied with a right angle applier and the
clip would circumferentially surround . the intFrnal
carotid artery and seal the aneurysm at its base. We
prefer this type of clip for repair of carotid artery
aneurysms, because these aneurysms arise from a
relatively wide portion in a relatively large vessel and
repair with a straight clip does not reinforce the base
or prevent the redevelopment of an aneurysm in the
future, and furthermore, should the base tear with
application, the clip seals the vessel. This is in direct
contrast to middle cerebral aneurysms, for instance,
in which ordinarily speaking one is able to find a
relatively thick base in the aneurysm to accept a
straight clip.
The s·e cond case is also an internal carotid
artery aneurysm, but this aneurysm arises not only
from the internal carotid artery but from the posterior communicatin'g artery as well, which in the
individual served as the sole source of blood supply
to the posterior cerebral artery on the side of surgery. We could not use a clip-graft for fear of occlusion of the posterior communicating artery; the aneurysm inust, therefore, be repaired with a Scoville clip,
a type of straight spring clip. Following clipping of
this aneurysm, a search made anteriorly to be certain
of the patency of the pos.terior communicating artery
showed it to be patent in this patient; and he made an
uncomplicated postoperative recovery.
The third case is that of an anterior communicating artery aneurysm. Viewed through the operating microscope in an approach along the floor of the
frontal fossa, the optic nerve would initially be identified and the dissection would be carried medially to
the location of the anterior communicating artery
and the aneurysm. Examination of the angiograms
prior to surgery revealed that this aneurysm projected anteriorly, and comforted by this knowledge,
the arachnoid overlying this lesion co~ld be dissected
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from between the two frontal Jobes at their base, just
anterior to the anatomical site of the vessel. Initially,
the aneurysm would be difficult to see, being surrounded by some thick fibrinous material, which in
turn was overlayed by arachnoid; these structures
served to seal the aneurysm when it bled. The aneurysm having been dissected anteriorly away from
the knee of the A-1 segment of the right anterior
cerebral artery and the anterior communicating artery, a clip would be placed tangentially at this point,
and following clipping, search would be made posteriorly to be certain of patency of the major vessels.
The final case relates to an anterior communicating artery aneurysm repaired with a clip-graft.
Both anterior cerebral arteries filled from the right
A-1 segment-a not uncommon configuration irt
this type of aneurysm; that is, all too frequently
both anterior cerebral arteries derive their blood supply from one side or the other through an enlarged
A-1 segment. Therefore in this instance it would be
particularly important to be certain that the anterior
communicating artery remained patent, and therefore, the clip-graft would be placed with the right
angle clip holder circumferentially around the anterior communicating artery sealing the small aneurysm projecting posteriorly at its base. The small
aneurysms are often much more treacherous than
the large aneurysms, because they do not offer a
large enough sac to accept dissection and occlusion
by a straight clip should they bleed.
Clinical Features and Diagnosis of Ruptured
Aneurysms. The sudden onset of an excruciating
headache, with or without the loss of consciousness,
indicates a subarachnoid hemorrhage until proven
otherwise. The patient describes an "explosion" in
the head ot a feeling of being struck behind the head
with a hammer. Some patients complain of pain on
one side, but more commonly the headache is primarily suboccipital in nature.
Often, the patient will have a seizure with his
first hemorrhage, but repeated seizures thereafter are
infreqi.1ent and anticonvulsants are usually not necessary. Patients may vary in their level of consciousness from alert to comatose following recovery of
the bleed.
Most patients appear acutely ill and in pain.
They complain chiefly of headache and commonly
of nuchal rigidity, which incidentally increases after
24- 48 hours. Blood pressure is commonly elevated.
The patients who have suffered more severe hemorrhages are confused, stuporous, semicomatosed, or
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even comatosed. In this group, lateralizing signs such
as hemiplegia, hemiparesis, or aphasia may be present. On the basis of the neurological symptomatology,
Botterell ( 6) described a system of classification
from grades I through V based upon the presence or
absence of findings indicated above. A grade I patient is one with only minimal symptomatology, primarily headache; a grade V patient is preterminal
and seldom considered a surgical candidate. Between grades I and V the classification is based
upon a level of consciousness and the presence or
absence of focal findings. This grading classification
has proved to be of immense help in considering results of both operative and conservative management.
Natural History of Subarachnoid Hemorrhage.
Various studies in the epidemiology of subarachnoid
hemorrhage from a ruptured intracranial aneurysm
have indicated the catastrophic nature of this illness. If a patient remains moribund for more than
24 hours after his initial bleed, his likelihood of
a one-year survival is 8% with rather a severe
morbidity; if he recovers from the bleed with only
minor symptoms present or a clouding of consciousness, his chances for a one-year survival are
approximately 50% (7, 8) . Furthermore, approximately 70 % of the patients with an aneurysm
demonstrated on angiography will have a second
hemorrhage, the peak incidence of which is in the
second or third week following the initial bleed (9) .
The second occurrence is usually more severe than
the first, frequently leaving the patient in a state of
unconsciousness or coma.
Timing of Surgery. Although it would seem
optimal to operate on the patient within the first
few days after the bleed in order to prevent a recurrent hemorrhage, experience in early surgery
from a variety of outstanding institutions has indicated the high morbidity of such a course of action.
Accordingly, almost all patients initially are managed
conservatively.
Initial Management by Clinician. The most important step in the care of a subarachnoid hemorrhage is the early diagnosis of a warning bleed by
the family physician. All too frequently the warning
bleed is unrecognized and only after a subsequent
and more severe bleed is the patient referred for
definitive management. A sudden, excruciating
headache with or without the Joss of consCiousness
is a subarachnoid hemorrhage until · proven otherwise. A careful atraumatic spinal puncture is necessary in the diagnosis of this illness.
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As soon as the patient recovers from the insult
of his first hemorrhage, he should be transported
by ambulance or air ambulance to a center where
such problems are handled in volume. These patients rarely represent acute surgical emergencies,
and except in instances of an associated large intracerebral or subdural hematoma, benefit from conservative management for the first several days
following hemorrhage. This period of bedrest is
perhaps even better for the patient in the setting
of the local facility than at the referral center. It is
disquieting for the clinician to have a patient with
a subarachnoid hemorrhage die prior to referral
or prior to obtaining a neurological consultation ,
but he can be comforted to know that bedrest with
light sedation and analgesic medication would have
been recommended for the first four or five days
or perhaps even longer at most major centers and
little could have been done by others that was not
done by himself.
One is tempted to lower the blood pressure
moderately in such patients with the hope of preventing a recurrence of bleeding while awaiting
surgery or diagnostic studies. There are currently
conflicting reports, however, regarding the usefulness of this measure and certainly it is not without
risk. As mentioned above, patients with a subarachnoid hemorrhage become pressure dependent
for cerebral perfusion; if a significant degree of
intracranial vasospasm is present, lowering the blood
pressure can result in cerebral ischemia and even
infarction. This is not to say that hypotensive treatment is not indicated in selected instances, but the
criteria are so complex for hypotensive management
that definite rules cannot be developed at present.
The use of dexamethasone or some other
steroid has been advocated by many experienced
workers in this field; others feel that the risk of
a stress ulcer is aggravated by an unproven beneficial
effect from this drug and have cautioned against its
use as a routine procedure. My personal experience
with the use of dexamethasone in this setting, in
marked contrast to its dramatic effect on the edema
of gliomas, has not been very encouraging.
Final data regarding the ability of £-aminocaproic acid to prevent a rebleed is not available.
My experience with this drug has not been good,
but admittedly we have not used it in the large dosages currently recommended.
Patients who have had a subarachnoid hemorrhage are particularly vulnerable to develop a type
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of inappropriate antidiuretic hormone (ADH) syndrome; therefore, moderate restriction of fluids is
recommended, so that the patient's total fluid intake
is between 1500 and 2000 ml daily. Serum sodium
should be drawn every 48 hours and if the patient
has a fall in the serum sodium, indicating extracellular volume expansion, fluids should be restricted
to 1000-1200 ml daily.
Spasm. Early surgery in this illness is risky
primarily because it accentuates and aggravates a
state of arterial spasm, a reaction to the vasoconstrictive effects of blood and its breakdown products
in the subarachnoid space ( 10). It is a diagnosis
based upon the caliber of intracranial vessels seen
on angiography; it may bei focal or generalized,
minimal or severe, unilateral or bilateral. Symptomatically it may produce evidence of both generalized and focal cerebral ischemia, the former manifested by an alteration in the level of consciousness
and confusion, the latter by a focal neurological
deficit. Although blood related, its etiology and
pathogenesis are far from being elucidated.
In general terms, the more severe and widespread the spasm, the worse the patient's clinical
condition . Extrapolating from our cerebral blood
flow data, it seems likely that spasm can be tolerated until a critical reduction in cerebral blood
flow occurs-probably somewhere in the level of
20-30 mljlOO gm/ min. Often, prior to this reduction in cerebral blood flow, an angiographic appearance of spasm will not be matched by the clinica'I
appearance of the patient; some individuals look
amazingly well considering the angiographic picture.
The reverse is not true; patients who show the
severe symptomatology of ischemia in this illness
usually have angiographic correlation not only with
evidence of focal vessel constriction but also of slowing of flow.
Recently, we have employed a combination of
isoproterenol (Isuprel®) and Jidocaine hydrochloride
(Xylocaine®) in the treatment of cerebral vasospasm ( 11) . Isuprel® is given for its beta-adrenergic
function and the Xylocaine® is used to counteract
cardiac arrhythmias that might result from the intravenous administration of Isuprel®. All patients have
had continuous EKG monitoring and special nursing
care. Both drugs are administered intravenously on
a continuous basis and should cardiac arrhythmias
result, the Isuprel® is decreased in its strength and
rate of administration or the Xylocaine® is increased
in its strength and rate of administration.
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There is a wealth of experimental evidence
to indicate that the conducting vessels in the subarachnoid space have a rich adrenergic nerve supply
which, after sympathectomy or subarachnoid hemorrhage, loses its fluorescence, indicating inactivation
of the granulated vesicles at the nerve endings.
These granulated vesicles are important not only
for metabolism, production, storage, and release of
norepinephrine but also for the control of function.
In contrast with cholinergic endings in which an
enzyme functions to destroy the freed acetylcholine,
the limited duration of action of the adrenergic
endings is thought to be related to the prompt
reuptake of norepinephrine by the granulated
vesicles. It is possible that some of the adverse
effect of blood on a vessel is the result of this type
of end-organ sympathectomy obliterating the function of the granulated vesicles and their buffer
action. Alpha and beta sites are pharmacological
concepts, not anatomical structures, and there is
evidence that between various vasoconstrictive
amines there is a competition for a type of membrane
response . Isoproterenol is given not so much as a
vasodilator but in an attempt to introduce a nonvasoconstrictive drug to compete at the end-organ
for the membrane response and hopefully thereby to
ameliorate the effects of vasoconstrictor substances
such as serotonin . Our laboratory studies indicate
that Isuprel® definitely does shorten the period of
basilar artery constriction from the topical application of blood .
Table 1 illustrates the author's experience with
the use of these drugs in operating on 159 patients
over the past four years. This table is primarily
intended to demonstrate the distribution of patients

TABLE 1
DISTRIBUTION OF TREATED* CASES AMONG ALL PATIENTS
OPERATED ON ACCORDING TO GRADE AND FINAL
CLINICAL RESULT

Final Clinical Result
Grade
I
II
III

IV
Total

* No.

Excellent

Good

63 (7)
32 (6)
14 (5)
2

3
1 (1)
13 (3)

111

1

18

Poor

Death

2
8 (2)
8 (4)

1
2 (1)
4
5 (1)

18

of treated patients is in parentheses.

12

with this problem as a major complication and
treated patients are identified in parentheses. The
result columns indicate the final clinical state of the
patient and not necessarily the response of the patient to the administration of these drugs. Most
patients treated in the grade I and grade II categories were treated following surgery for the onset
of a progressive neurological deficit. Most patients
treated in the grade III and IV categories were
treated prior to surgery in an attempt to arrest a
progressive neurological deficit or improve their
condition to a point where surgery could be tolerated.
Patients who did not undergo surgery are not illustrated and not included.
A retrospective analysis of the results of the
use of these drugs indicates that no improvement
has been noted, if the drugs have been used after
a period of two hours from the time of the onset
of the neurological deficit. Obviously, the more severe the deficit, the more important it is that
therapy be instituted early. Although an occasional
dramatic response has been noted, most commonly
a progressive deficit is halted with a rather major
recovery in the first 48 hours, and recovery thereafter related only to the predicted improvement
and recovery pattern seen in patients with regions
of focal ischemia. The drugs are, however, with
careful monitoring, safe, and we have had no
mortality from their use . It now remains for others
to judge the merits and demerits of this program .
Thirty patients treated in this group are shown ;
treatment was discontinued in another five because
of arrhythmias.
In considering and analyzing the results of any
medications, it is necessary that they be evaluated
in properly selected patients. Spasm , as a major
complication, was not uniformly seen in the patient
group and although most morbidity and mortality
is noted in the high-risk patients, grades III and IV,
death and morbidity in these patients was not always
a result of their preoperative state. Poor results and
death in this group include one patient who bled
in the hall prior to entering the operating room,
one who bled during the induction of anesthesia,
two who sustained a recurrent hemorrhage-the
result of poor aneurysmal repair, and two who had
occlusion of a major parent vessel from which a
giant aneurysm arose. A permanent Korsakoff's
syndrome accounted for a poor result in two patients
(one of whom had a giant aneurysm and predated
surgery). This syndrome, although occasionally the
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result of spasm, is more commonly a complication
of surgical trauma in the septa! or preseptal area.
Conclusion. Improved neuroanesthesia and surgical techniques, especially including magnification
of vision and an intense light source, have drastically
lowered the operative mortality and morbidity in
aneurysm surgery; however, because of a delay in
surgery to avoid major vasospasm, many patients
are lost from rebleeding. Until a solution to the
complication of vasospasm is obtained, most major
institutions still prefer to delay surgery. Isoproterenol
and lidocaine seemingly ameliorate this dreaded
complication but are certainly no panacea and we
are still looking forward to a final miracle drug
from one of our sister institutions (12).
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Clinical Advances in the Evaluation of Deep Coma***
CARY SUTER, M.D.
Chairman, Department of Neurology, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University,
Richmond

Today, 1974, in large medical centers, evaluation of the patient in coma is almost a d_aily necessity, and the need to evaluate the patient in deep
coma arises once or twice every week. Even in
smaller hospitals the problem is not uncommon.
This has come about because many laymen and
most medical personnel are now well trained in
methods of cardiorespiratory resuscitation (1, 2).
Persons are not allowed to die easily and once
resuscitated, are moved to intensive care units where
life is maintained. Fortunately, if they do not die
of their underlying disease, such as trauma or
myocardial infarction, many patients thus rescued
recover completely; that more do not is due to the
fact that the brain is such a tender organ-only
a few minutes without oxygen and neurons die or
are damaged-only a short while without blood
flow and, apparently, the cerebral blood does not
flow again. On the other hand, neurons, silenced
completely by drugs for hours or even days, may
recover and soon be alive and well.
A proper decision as to the cause and degree
of brain damage may lead to useful treatment and
recovery or, if the brain is dead, may allow other
organs to be used for transplantation and relieve
the family, as well, of hours of anguish and added
expense. In 1966, Plum and Posner ( 3) outlined
in an orderly fashion the various clinical observations necessary for the evaluation of the ordinary
comatose patient. They did not, however, give special
attention to the patient in deep coma or the problem of possible brain death. The problem of diagnosing deep coma and determining brain or cerebral
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death became more urgent with the advent of widespread organ transplantation. Although at first, the
problem of evaluation of deep coma was approached
by each specialist from his own area of expertise,
a combination of clinical examination and laboratory tests has now been developed which promises
to allow routine and relatively rapid diagnosis and
prognosis. Impetus for such an approach in the
United States first came in 1968 from the report
of the ad hoc committee of the Harvard Medical
School ( 4) to examine the definition of brain death.
These so-called "Harvard Criteria" were primarily
a combination of clinical examination and electroencephalogram recording. Standards for acceptable
electroencephalographic recording were further
studied and summarized by an ad hoc committee
on '"EEG Criteria for a Demonstration of Cerebral
Death" ( 5) of the American Electroencephalographic Society published in 1970. While these and
other studies ( 6, 7) emphasized the usefulness of
the EEG in the evaluation of deep coma, investigators in Europe demonstrated the usefulness of
cerebral arteriography and the assessment of cerebral blood flow as prime criteria for the determination of brain death ( 8-10). Further refinements of
the clinical and EEG evaluation of deep coma will
soon be available in the report of the Na ti on al
Institutes of Health Collaborative Study on Cerebral Survival ( 11) . This study of over 500 patients
also emphasizes the clinical examination and the
electroencephalographic study; however, it will include the report of an ancillary study on a rapid
bedside method of assessing cerebral blood flow
by the injection of radio isotopes-the Bolus technique (12).
At the Medical College of Virginia, we became
interested in the problem of acute bedside recording
in the mid-1960's, particularly in relationship to
patients with seizures and strokes. We were espeMCV QUARTERLY 10(3): 152·162, 1974
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cially interested in changes in patients with cerebral
emboli who often presented with continuous focal
seizures (13). This interest was expanded to include patients in deep coma, primarily for the
purpose of making decisions related to organ transplant. For over five years, we have maintained
regular 24-hour EEG coverage in the Medical College of Virginia Hospitals. Beginning in 1971, we
took part in the National Institutes of Health Collaborative Study on Cerebral Survival ( 11). From
this experience, and a survey of recent literature,
comes the following assessment of our presen~ approach to the diagnosis of the patient in deep coma.
The main items of importance in the process are
presented below.
Clinical Ex~mination. Responsiveness to stimuli
is basic to the definition of coma. Persons in deep
coma do not respond to the spoken word at all;
they do not respond in any purposeful manner
but only by reflex movement to other stimulation.
With deep pain, they may respond not at all or
respond by reflex movement such as decorticate or
decerebrate posturing. In some cases, eye blinks,
either spontaneous or to stimulation, may occur
and occasionally chewing movements. Ariy easily
elicited response, particularly of a purposeful nature
to any stimuli, suggests that the patient is not in
deep coma.
The presence or absence of spontaneous respiration is, of course, a critical point in the evaluation of deep coma. With brain death, including
the cerebral cortex as well as the brain stem, there
will be no spontaneous respiration. With cerebral
cortex damage alone, but with brain stem function
intact, respiration may be nearly normal. This accounts for the rare situation of a patient showing
electrocerebral silence on EEG with some loss of
other cranial reflexes who surprisingly breathes
spontaneously after the mechanical respirator is
disconnected. These are the patients who may survive for months or years with an EEG showing
electrocerebral silence. This also indicates the necessity of carefully testing all cranial reflexes before
cerebral death is pronounced. In general, the absence of spontaneous respiration is a bad prognostic
sign in patients with structural lesions, such as
cerebral hemorrhage or trauma, and to a considerable degree in patients with cerebral anoxia. Patients
in coma from overdose, however, may not have
spontaneous respiration for a considerable period
of time and still completely recover.
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The Harvard criteria emphasize the absence
of all reflexes, both cranial and spinal, and the lack
of spontaneous respiration as the prime elements
in the clinical examination. Experience in the Collaborative Study on Cerebral Survival ( 11) has
confirmed the i!llportance of cerebral reflexes. In
this regard, the pupillary reflexes are the most important since fixed dilated pupils (not necessarily
maximally dilated) and absence of respiration are
the most common clinical accompaniment of brain
death. The presence of oculocephalic reflexes indicates that brain stem structures are still alive. The
presence of oculovestibular reflexes also suggests
the presence of functioning brain stem structures,
but this reflex seems to persist longer than the
oculoceph<ilic reflex. The response of eye blinks,
either as ;i reflex or spontaneously, also indicates
some brain stem function and since this is routinely
recorded in the electroencephalogram, it serves as a
reminder to the electroencephalographer that brain
stem function persists, even though the recording
may show electrocerebral silence otherwise (Fig. 1).
It :may be noted that the examination of the
optic fundi is not included as an important factor
in determination of cerebral death. Although examination of the optic fundi may help in the etiological diagnosis of coma, it is of little direct help
in prediction of the level of coma or its outcome.
Information of the presence or absence of blood
flow in the retinal vessels is not sufficiently accurate
to serve as a criterion of brain death.

EKG

c,-A,
eye ·blinks

o,-A,

Arm

Fig. 1-This record shows eye blink, muscle, and EKG
artifacts. After succinylcholine injection the muscle and
eye blink artifacts were abolished and no evidence of cerebral activity remained. Despite this fact, the patient is still
alive, nine months after cardiorespiratory arrest. The patient still remains in coma but breathes spontaneously.
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One result of our e~perience in the cerebral
survival stµdy is the und~rstanding that spinal reflexes are completely unreliable in the prediction
of brain death or of the ou.teome of coma. Although
the paper outlining the Harvard criteria js not
exactly clear ori this point, it suggests the absence
of spinal reflexes as part of the criteria; this is
one part of the Harvard criteria that may definiteiy
be discarded. Although spinal reflexes are often
absent, patients in deep coma may show some degree of r~flex movement as well as actual muscle
stretch reflexes and evc:n Babinski signs. Such reflexes, of course, may be suppressed in pa~ients with
drug overdose, and yet the patient may still recover
completely.
·
Convulsions or myoclonic jerks are common
during the 12-24 hours immediately following cerebral damage from anoxia due to cardiac arrest.
During this time, the EEG may indeed show no
clear activity except the artifacts produced by such
movements. With the use of succinylcholine or
Valium®, the cerebral discharges alone can be
recorded. The oq:urrence of coµvulsions or diffuse
rhythmic myoclonic jerks can be taken as proof
of some brain fonctjon.
Blood pressure, as such, is of little value in
the evaluation of the patient in deep coma. It is
true, however, that a sudden fall of blood pressure
is often a terminal event in a patient with brain
death maintained on a respirator for a long perioq.
lt is also apparently true that in patients with cerebral trauma or cerebral hemorrhage, the presence
of excessively high blood pressure is a bad prognostic sign (14) . Thus, excessive alteration, either
up or down, of the blood pressure is a sign of poor
prognosis ( 15).
Temperature is of importance mainly because
extremely lo'!" temperature may alter cerebral activity and be associated with eler;:trocerebral silence
in the patient who eventually survives. Slight lowering of temperature does not seem to have this
effect. In the ordinary case of deep coma, therefore,
temperatµre is of no major importance.
In summary, of all the clinical observations
of the patients with deep coma, those having to do
with cranial reflexes, particul;uly the pupils, and
with respiration, are the most important.
Tests for P~gs and Metabolic Abnormalities.
Since recovery from deep c9ma in patients with
electrocerebral silence on the EEG is seen alrµost
exclusively in patients whose coma is due to drug
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overdose or metabolic derangement, the diagnosis
of toxic and metabolic factors in coma is of great
importance. Experience in this regard suggests that
tests for metabolic derangement, at least ordinary
metabolic derangement, are rapidly and easily obtained. The same is not true of toxicology. Even in
large tpedical centers, it is often difficult to obtain
rapid, reliable, quantitative tests for drugs and toxic
substances. While it is true that drug levels are not
important in cases of clear trauma or of anoxia
ser;:ondary to cardiac disease, occasionally the two
conditions may coincide. For this reason and because of the legal implications, improvement of our
services in this area is urgent ( 16) . r;ven though
rapid toxicology reports may become available in
large medical centers, it will remaiµ a difficulty for
some time in smaller hospitals. fortum1tely, evidence at this point suggests that usually the patient
in deep coma can have an adequate evaluation
without knowing the actual drug · levels. For instance, in our experience, no patient with dilated
pupils and electro~erebral silence on the electroencephalogram has survived. Since such a case might
exist, however, due to . drug overdose, this is an
area if! which the use of a rapid simple test of
cerebral blood flow would help give a final answer
concerning cerebral death without reference to drug
levels ( 10) .
Another recurring problem of patients in deep
coma, particularly with anoxic coma, has . to do
with the fact that many present with convulsive or
myoclonic seizures. Such patients are often treated
with rather large doses of anticonvulsant drugs
which are also sedatives. Obviously, it is not appropriate to accept clinical and EEG evidence of
brain death in the patient who has just been given
large doses of such drugs. Quantitative drug levels
are necessary before final decisions can be made.
Electroencephalogram. The importance of the
electroencephalogram in the evaluation of coma
has escalated in direct proportion to the 24-hour
availability of such recordings, the excellence of the
recording technique, and the experience of the electroencephalographer. When these criteria are met,
the electroencephalogram is indispensable in the
diagnosis and prognosis of deep coma.
Meticulous technique is the mark of the excellent EEG technician and the true electroencephalographer. The model of such meticulous
technique was established by Hans Berger ( 17)
in his extensive studies to prove that the oscillations
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of his recorders were due to cerebral activity and
not to artifact. Modern electroencephalographers
have retraced Berger's steps with the opposite intent,
namely to prove that the oscillations are artifact
and not cerebral activity.
Fortunately, with present equipment, excellent artifact-free records may be obtained in even
the most chaotic intensive care unit. Adequate technical recording requires that records be made at
a very high amplification with portions of the record
being recorded with al) amplification of twd microvolts per millimeter. It is then necessary that ail
deflections of the recording be clearly identified
either as artifact or as cerebral activity. Common
artifacts come from the electrocardiogram, from
rriechanical respirators, from cardiac monitors, and
from other monitoring equipment. Any slight movement of the bed or patient may present a problem.
When ~hese artifacts cannot be eliminated, they
can at least be monitored as a part of the actual
recording. Figure 2 shows respirator artifact and
electrocerebral silence when the respirator is briefly
stopped. Figure 3 shows the monitoring of the
respirator cycle by an accelerometer actually attached to the respirator instrument.
The most consistently bothersome artifact is
that of muscle activity. Even in deeply comatose
patients and even in patient~ without brain stem
function, some muscle activity may remain. Fortunately, since such patients are on respiratory
support, the use of succinylcholine given intravenously to abolish muscle artifact is an extremely
useful procedure. This is particularly true since
in a review of our records on patients in deep
coma, the type of record which was most con~
sistently thought to be technically inadequate was the
record with muscle artifact. Particularly records
with low amplitude artifact due to muscle alone
may_ be thought to show low-fast brain activity.
Figure 4A shows such a record and the recording
after succinylcholine (Fig. 4B).
As regards the Harvard criteria ( 4), our
studies have shown that all patients with a single
record of thirty minutes of electrocerebral silence
with no spontaneous respiration and with dilated
fixed pupils have died. A recent report of Jorgensen
(18, 19) from Copenhagen reaches this same conclusion, except that he adds to the criteria the loss
of spontaneous maintenance of systemic blood
pressure.
Aside from the useftilness of the electroen-
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Fig. 2-The first record shows regular, recurring respirator
artifact. The second record shows the disappearance of this
artifact when the respirator is stopped. Though some very
slight muscle attifact relnaiiJ.s, the record after the respirator is stopped is essentially that of cerebral silence.

· cephalograin iri the recording of electrbcerebral
silence in cases of brain death, experience in a
great variety of patients with lesser degrees of .coma
has given a new appreciation of certain distinct
EEG patterns (13, 20-27). Such distinetive EEG
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Fig. 3- Monitoring of the respirator cycle by an accelerometer is demonstrated in Channel 3. Although the recording is that of electrocerebrai silence and no marked respirator artifact appears, a slight swaying of the baseline in titne
with the respiration can l:ie detected in Channels 5 & 6.
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Fig. 4A-This record shows low amplitude fast activity in
the sixth channel from electrodes C, and 02. This might be
considered cerebral activity.

patterns seen in patients in coma are presented
below.
Electrocerebral Silence. As recorded in the
electroencephalogram, electrocerebral silence consists of no deflections above a millimeter with the
machine set at an amplification of two microvolts
per millimeter. Actually, some older machines have
a background noise level of two-to-three microvolts
and in tnis situation, some leeway will have to b~
given for determination of electrocerebral silence.
In the newer machine with everything in order, a
record without deflections beyond a one-millimeter
range should be obtainable. Nevertheless, it is
usually impossible, except by special subtraction
or computer techniques, to remove all of · the EKG

artifact from the record (28). This usually appears
as a regular deflection which can be monitored and
determined to be directly synchronous with the
EKG (Fig. 5).
Low Amplitude-Fast Activity (Muscle) Abolished by Succinylcholine. Low and high amplitude
muscle artifact is seen in many recordings, even in
patients with severe damage of the brain stem.
It occurs in patients who already have dilated
fixed pupils and no spontaneous respiration. If
these patients are continued on respiratory support,
eventually all muscle activity ceases. The muscle
activity may be the only remaining artifact that
makes it impossible to be sure the record is that
of electrocerebral silence. Also, the muscle artifact
may appear actually as beta activity. Since beta
activity is often seen in patients with overdose who
will survive, it is extremely important that this
differential be made. This can be done by a single
injection of 30-60 mg of succinylcholine intravenously or, better yet, by a slow constant drip of
succinylcholine ( 29-31). This is done, of course,
only on patients with respiratory support (Fig. 4B).
Electrocerebral Silence Except for Myoclonic
Jerks. We have observed, particularly early in the
course of deep coma and especially in coma due
to cerebral anoxia, that the patient may present
with repeated myoclonic jerks, but the recording,
except for these jerks, shows no cerebral activity
(Fig. 6). Succinylcholine given in this situation
has to be given in very large amounts to block
the myoclonic jerks. Drugs such as diazepam may
block the myoclonic jerks but then raise the question as to whether the drug might also suppress
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~i~. 4B-~ter succinylcholine the low amplitude fast activity seen m Channel 6 disappeared and therefore was due
to muscle. artifact. The recording is now that of electrocere bra! silence.
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Fig. 5-At a recording amplitude of 2 µ V / mm, no discernible cerebral activity appears and this is a typical
record of electrocerebral silence. Very slight EKG artifact
is seen.
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other cerebral activity. In general, this type of
record is usually, but not always, a very poor
prognostic sign. The fact that myoclonic jerks exist,
particularly as they are bilateral and symmetrical,
indicates that some brain function remains.
Burst Suppression Pattern. In many records
of deep coma, particularly due to cerebral anoxia
and often following a few hours of records which
show only myoclonic jerks, there may occur a burst
suppression pattern. In this situation, fairly high
amplitude complexes, either singly or in paroxysmal
episodes, occur with intervening periods of electrocerebral silence. The intervening period may vary
from one or two seconds up to a minute or more.
Such a burst suppression pattern, in general, is a
bad prognostic sign (Fig. 7).
PLED's and "Bilateral" PLED's. In a great
number of patients with cerebral emboli or other
lesions, particularly associated with some metabolic
disturbance, bilateral, semirhythmic, periodic discharges are seen but these discharges are definitely
greater on one side. Often associated with these
discharges, there are brief but continuous myoclonic
jerks. In our laboratory at the Medical College of
Virginia, these were observed in the early 1960's
and designated "acute spikes" ( 13). They also
have been described and usually called "PLED's"
(periodic lateralized epileptiform discharges) in the
literature (32) . Most patients with this pattern are
stuporous but may be conscious; depending upon
the lesion involved, they may proceed with it and
die or they may recover completely. It is thought
that the cerebral ischemia, resulting from embolization which has produced a temporary anoxia, causes
the unilateral discharges. In any case, a similar pattern, bilaterally symmetrical, is seen following severe
cerebral anoxia of a diffused nature such as that due
to cardiac standstill. In this situation, the bilateral
PLED's have a much more serious prognosis (Fig.
8A , B).
Continuous Spike or Spike Waves. Certain
patients who are stuporous or in coma present
with continuous diffuse spike or spike wave discharges. Some of these patients have a chronic form
of convulsive disorder and are in a type of convulsive state. Such patients are not usually confused
with deep coma, since reflexes remain and pupils
react, and the patient breathes spontaneously. Following a reasonably severe anoxic insult, however,
certain patients also go into a period of one, two, or
three days of continuous diffuse spike and spike wave
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Fig. 6-ln this record myoclonic seizures such as seen in
the beginning of the recording occur every 10-30 seconds.
Succinylcholine suppressed other muscle artifact revealing
no evidence of cerebral activity between these attacks.

activity (Fig. 9). This may precede a more severe
continuous burst suppression record, or it may
precede a longer period when the patient simply
has a theta coma. A few of these patients recover,
usually with some degree of neurological damage.
Control of such activity with anticonvulsant drugs
usually does not produce an electrocerebral silence
record but tends to produce a record with either
delta or theta activity, so that there is no problem
concerning decision as to electrocerebral silence.
Severe Asymmetry. A record with severe asymmetry, particularly showing essentially electrocereBURST SUPPRESSION PATTERN
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Fig. 7- This record shows relatively high amplitude discharges occurring in a rhythmic fashion with only low
amplitude activity between. Such discharges appearing
over a period of time in general have a bad prognostic
significance.
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Fig. SA-This is a record showing typical periodic lateralized epileptiform discharges (PLED's) secondary to cerebral
embolus to the right hemisphere in a patient with some
metabolic derangements.
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bral silence on one side and large delta activity
on the other, is seen primarily in cerebral trauma
but occasionally in intracerebral hemorrhage. Such
a record indicates a poor prognosis for complete
recovery, though dependent upon the treatment
carried out and the nature of the illness, the patient
may survive (Fig. 10). Lesser degrees of asymmetry
seen in ordinary subdural hematoma, of course, may
be followed by complete recovery of the patient and
normality of the EEG.
Diffuse Delta. Classically, diffuse delta activity
has been associated with coma or diffuse brain
damage or disease. Actually, this is not a very
frequent pattern in the patient in deep coma. The
presence of diffuse delta may indicate any of a
great number of relatively acute cerebral disturbances which may be transitory. Thus, many patients
who show diffuse delta and periods of coma or confusion recover completely. This is particularly true
following metabolic happenings and following closed
head trauma (Fig. 11).
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Fig. 9-This record shows continuous spikes and spike waves
in a diffuse fashion due to an acute cerebral anoxia.

Diffuse Theta (Theta Coma). We have observed
a number of patients with a fairly regular diffuse
theta activity in the electroencephalogram ( 25). This
activity is often seen during a recovery stage following cerebral anoxia of a severe degree. At this
point the patient may deteriorate and revert to burst
suppression and eventually to electrocerebral silence
but more often shows a tendency toward recovery.
This finding of theta coma is of importance directly
in proportion to how long it occurs. As a transient
happening, it has a good prognosis in general; if
theta coma pattern persists for days or weeks, however, it is usually in association with a patient who
has received rather severe diffused cerebral damage
as well as some brain stem damage. Such patients
usually breathe spontaneously, have some pupillary
reflexes, but do not respond in purposeful fashion
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Fig. SB-This is a recording showing periodic generalized
discharges or so-called bilateral PLED's in a patient with
diffuse cerebral anoxia secondary to cardiorespiratory arrest.
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Fig. IO-This record shows marked asymmetry with severe
depression over the left hemisphere secondary to a large
subdural following trauma in the so-called "battered child."
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Fig. 11- This record shows diffuse delta in a patient
comatose following a hypoglycemic episode.

to stimuli. They may stay in this state for long
periods of time (Fig. 12).
Diffused "Sleep Spindle" Activity. Reports have
appeared concerning sleep spindle activity in coma
associated with brain stem lesions (24), particularly
in pontine lesions. We have seen one particularly
impressive case with a cerebellar hemorrhage and
brain stem compression. This type of record may
be confused with records in drug overdose which
may also show sleep spindles. The presence of such
a record in a deeply comatose patient, however,
should always raise the possibility of a brain stem
lesion and compression by a cerebellar lesion, particularly since this may be a treatable situation
(Fig. 13).
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Fig. 12- This record shows so-called theta coma with
predominant discharges in the 4- 8 c/sec range in a diffuse
fashion. This patient had severe diffuse cerebral damage
following cerebral anoxia but, though comatose, was still
breathing spontaneously and making nonpurposeful movements to stimuli two months following the injury.
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Fm. 13-This record shows diffuse spindle activity resembling sleep in a patient with a cerebellar hematoma and compression of the brain stem. Removal of the hematoma resulted in nearly complete recovery of the patient.

Diffuse Alpha Frequency (Alpha Coma). Reports of normal electroencephalograms in patients
in coma have appeared (26, 27). What is usually
meant by this is that the patient has an alpha
frequency discharge which occurs in a diffuse fashion. Actually, such a diffuse alpha frequency discharge is quite abnormal and is indeed usually
associated with coma secondary to pontine or brain
stem lesions or damage. Most such patients have
died; however, we have recently recorded such
alpha frequency coma in several patients who survived (33) . Two of these had coma following
severe accidental electroshock and one had coma
following cerebral vascular insufficiency attack. It
would appear that recovery is not unusual in patients with alpha frequency coma, particularly when
the alpha frequency coma is of brief duration
(Fig. 14).
Diffuse Beta (Beta Coma). The occurrence of
diffuse beta activity is usually a sign of drug overdose and is seen in patients who are not in really
deep coma; occasionally, however, it is seen in patients with brain stem lesions. The literature is
somewhat confused on this subject, since some of
the recordings thought to be beta activity probably
actually represent low amplitude muscle activity
which could have been abolished by succinylcholine.
Usually, the recording of a diffuse beta activity
record is a good prognostic sign, because it is
usually related to drug overdose (Fig. 15).
These are some of the characteristic patterns
with which we have become familiar in the study
of coma. As time goes on, and larger numbers of
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Fig. 14-This record shows so-called alpha frequency coma
in a patient comatose following cardiorespiratory arrest
from a severe electric shock. The patient remained comatose
for nearly three weeks but then slowly regained consciousness and is still living with a large degree of recovery but
with some slight memory and learning defect.

cases are collected, more definite prognostic attributes can be given to each type of finding.
Determination of Cerebral Blood Flow. Although our experience indicates that a careful clinical
examination and excellent electroencephalographic
recording give enough information, even within 3090 minutes, to make a decision as to the presence
of brain death (dilated fixed pupils, no spontaneous
respiration, and electrocerebral silence EEG for
thirty minutes equal brain death), the addition of
information about cerebral blood flow might increase
ones sense of confidence in cases where drugs or
metabolic abnormalities might be active. For this

.Fig. 15-This is so-called beta coma seen in a patient
with a drug overdose who was comatose but who recovered
rapidly and completely.
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reason, studies of the possibility for developing
facilities for the easy evaluation of cerebral blood
flow should be continued. In this regard, the Bolus
technique shows prominence ( 10). In this test,
radioactive material is injected into the veins and
the resulting radiation is picked up within a few
seconds from the cranium and from the chest or
the femoral artery. This is a qualitative not a quantitative test, but in patients with brain death, essentially no blood flow is recorded over the cranium
and the normal flow is recorded in the chest or
femoral artery probe. This test has not yet been
firmly authenticated with contrast cerebral arteriography, but so far its correspondence with other
studies is excellent. Because it represents a relatively simple bedside test, could be available in a
large number of hospitals, and offers confirmation
of brain death from a different parameter, it may
indeed have widespread application .
It is assumed that in a case of severe drug
overdose without cerebral anoxic damage or cerebral
infarction, the cerebral blood flow would be present
and, if not normal, at least not severely depressed.
For this reason this test would become an ideal
test on a patient with drug overdose who had remained comatose with electrocerebral silence for
a period of 12-24 hours. In similar cases, where
ordinary contrast cerebral arteriography has been
performed, it has shown no cerebral blood flow in
patients even with overdose after 24 hours. This
is almost certainly due to the fact that these patients
have also suffered anoxic damage. Even now, when
doubt exists, ordinary contrast cerebral angiography
can give essentially the same type of information
and should be used more often here in the United
States as it is now being used in Europe.
Other Tests. At this point, it does not appear
that tests and examinations other than those listed
above will become critical in the examination of
brain death; nevertheless, a variety of other laboratory procdures will, as time goes on, help us to
understand particular types and particular degrees
of brain damage. There have been a large number
of reports concerning values in the cerebral spinal
fluid of pH, lactic acid , and a variety of enzymes
related to the stage and degree of brain damage
(34, 35) . In general, we have not carried out
lumbar puncture or cerebral spinal fluid examination routinely in patients with deep coma, since in
some cases this might be contraindicated because
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of increased intracranial pressure or other intracranial lesions.
The more widespread use of monitoring intracranial pressure assures our better understanding
of what role increased intracranial pressure has in
the development of deep coma and at what points
it might be reversed by various forms of treatment
( 36). From a few observations, it might appear
that when the intracranial pressure passes a critical
point in relation to systemic blood pressure, severe
brain damage follows rather rapidly. So far, the
monitoring of intracranial pressure has been largely
in patients with trauma or hemorrhage, but it would
appear to be a reasonable procedure in most patients in deep coma.
What of the Future? As the assessment of the
patient in deep coma becomes more exact and
routine, it is reasonable to expect continued progress
in both diagnosis and treatment, particularly in the
following areas: 1) The routine collection and correlation of data concerning the clinical examination,
drug and metabolic levels, electroencephalogram, and
cerebral blood flow will allow dependable decisions
concerning cerebral brain death to be made at any
point in the patient's course in a matter of one or two
hours. As outlined previously, some combinations
of these findings will supplant the Harvard criteria
( 4) as a dependable basis for determining cerebral
or brain death. 2) Complete assessment of the
patient in coma will occur earlier and nearer the
time of the original insult to the brain, thus allowing
a better understanding of the patterns of evolving
brain damage or recovery. 3) An understanding
of the usual course of coma in particular situations,
such as cerebral trauma, cerebral anoxia from
cardiac standstill, cerebral hemorrhage, drug overdose, and so forth, will allow better management
and better judgment of prognosis in each particular
situation. 4) A number of distinctive EEG patterns
seen in deep coma will be more widely recognized
and their significance will be validated by large
series of cases. 5) Criteria concerning evaluation
of deep coma which, at present, apply mainly to
adults will be expanded to include an understanding
of the situation in infants and children. 6) As clinical information and information from laboratory
work accumulate, useful means of altering the
course of severe brain damage by the application
of a variety of medical and surgical treatments will
be found.
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Chromosome Abnormalities and Repeated Abortion:
A Preliminary Report
SUSAN ENGLISH, B.A., DEBORAH W. HERITAGE, B.A., M.S.,
ANDREW T. L. CHEN, PH.D., REUBEN B. YOUNG, M.D.
Program In Human Genetics and the Department of Pediatrics,
Medical College of Virginia, Health Sciences Division,
Virginia Commonwealth University, Richmond

The role of chromosome aberrations in the
etiology of early spontaneous abortions has been
well established (1). Various investigators have
found that 25-35% of all such abortions are the
result of cytogenetic abnormalities (2, 3). The great
majority of these aberrations are believed to be the
result of de novo errors in meiosis and only rarely
can early mitotic mistakes account for these events
(3). In a minority of cases, one of the parents may
harbor a transmissible chromosome anomaly. The
carrier is apparently physically normal and has a
balanced genetic make-up compatible with life. During gametogenesis, however, unequal gametes may
be formed, resulting in development of a nonviable
zygote. This may predispose the carrier to recurrent
early abortion of his or her offspring.
Recently, a number of studies have attempted to
find such a correlation between recurrent pregnancy
loss and parental chromosome anomalies (3, 4, 5,
6). An investigation of this type was initiated at
the Medical College of Virginia in the fall of 1973.
Letters were sent to obstetricians in eastern Virginia
requesting referrals of patients with histories of two
or more spontaneous abortions. Blood was drawn
from both the husband and wife and karyotype analysis was performed according to conventional methods. Five anomalies have been ascertained in the
25 couples studied so far. A discussion of the significance of these findings is considered below.
A 28-year-old white female was found to have a
modal chromosome number of 47. The patient was
MCV QUARTERLY 10(3): 163, 167, 1974

intelligent and physically normal with a history of
two spontaneous abortions and no live births. Karyotype analysis, banding studies, and buccal smears
showing two sex chromatin bodies in 31 % of 800
cells analyzed confirmed that the patient was a
triplo-X female. The incidence of 47,XXX females
is believed to be about one per 1000 in the normal
population (7). Due to wide phenotypic variability,
a clearly defined triplo-X syndrome has not been
established. Fertility is thought to be unimpaired (8).
There is, however, a slightly increased risk of sex
chromosome anomalies in the offspring.
Chromosome polymorphism was detected in a
30-year-old white female with a history of two early
spontaneous abortions. Satellites on chromosome 17
were seen consistently in all preparations. A polymorphism of this type is not believed to contribute
to repeated fetal wastage (4), although the possibility cannot be ruled out until prospective studies
are done. The patient was in the seventh month of
an uneventful pregnancy when the study was done.
Another structural polymorphism was discovered in a husband whose wife had experienced three
spontaneous abortions and no live births. The husband's karyotype was 46,XY with an enlarged #16
chromosome. The clinical significance of this finding
is not known at present, and the patient's chromosomes are being studied with banding techniques.
One of the most interesting findings was tbe ascertainment of two families with balanced D /D
(Continued on page 167)
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how big a dose will now
bring relief if it is a narcotic?
"Tolerance is an ever-present hazard to continued use
of narcotics .. ..The very first dose diminishes the
effects of subsequent doses. "1 And, as increasing
amounts of narcotics are required to control pain, distressing adverse effects- lethargy, hypotension, constipation, etc.- can needlessly debilitate the patient.
1. Sadove, M. S.: A look at narcotic and non-narcotic analgesics,
Postgrad. Med. 49:102, June 1971.

how big a dose will now
bring relief if it is Talwin®?
Chances are, the same 50 mg. Talwin Tablet you prescribe originally will continue to provide good pain
relief. Talwin can be compared to codeine in analgesic
efficacy: one 50 mg. tablet appears equivalent in analgesic effect to 60 mg. (1 gr.) of codeine. However,
patients receiving Talwin Tablets for prolonged periods
face fewer of the consequences you've come to expect
with narcotics. There should be fewer "adverse effects"
on her way of life.
Tolerance rare: Tolerance to the analgesic effect of Talwin
Tablets is rare.
Dependence rare: During three years of wide clinical use,
there have been a few reports of dependence and of withdrawal symptoms with orally administered Ta/win. Patients
with a history of drug dependence should be under close
supervision while receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should
take precautions to avoid increases in dose by the patient
and to prevent the use of the drug in anticipation of pain
rather than for the relief of pain.*

Generally well tolerated by most patients*: Infrequently
causes decrease in blood pressure or tachycardia; rarely
causes respiratory depression or urinary retention; seldom
causes diarrhea or constipation. Acute, transient CNS effects,
described in product information, have occurred in rare
instances following the use of Talwin Tablets. If dizziness,
lightheadedness, nausea, or vomiting is encountered, these
effects may decrease or disappear after the first few doses.
•see important product information for adverse reactions, patient
selection, prescribing and precautionary recommendations.

in chronic pain
o f moderate to severe intensity

Ta1'1Vift®:::u

Talwin® Tablets brand of pentazocine (as hydrochloride)
Analgesic for Oral Use Indication: For the relief of moderate to severe pain .
Contraindication: Talwin should not be administered to patients who are
hypersensitive to it.
Warnings: Drug Dependence. There have been instances of psychological
and physical dependence on parenteral Ta/win in patients with a history of
drug abuse and, rarely, in patients without such a history. Abrupt discontinuance following the extended use of parenteral Ta/win has resulted in
withdrawal symptoms. There have been a few reports of dependence and of
withdrawal symptoms with orally administered Ta/win. Patients with a history of drug dependence should be under close supervision while receiving
Ta/win orally.
In prescribing Ta/win tor chronic use, the physician should take precautions
to avoid inqeases in dose by the patient and to prevent the use of the drug
in anticipation of pain rather than for the relief of pain.
Head ln1ury and Increased Jntracranial Pressure. The respiratory depressant
effects of Talwin and its potential for elevating cerebrospinal fluid pressure
may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a preexisting increase in intracranial pressure. Furthermore, Talwin can produce effects which may obscure the clinical course of
patients with head injuries. In such patients, Talwin must be used with extreme caution and only if its use is deemed essential.
Usage in Pregnancy. Safe use of Talwin during pregnancy (other than labor}
has not been established. Animal reproduction studies have not demonstrated teratogenic or embryotoxic effects. However, Talwin should be
administered to pregnant patients (other than labor} only when, in the judgment of the physician, the potential benefits outweigh the possible hazards.
Patients receiving Talwin during labor have experienced no adverse effects
other than those that occur with commonly used analgesics. Talwin should
be used with caution in women delivering premature infants.
Acute CNS Manifestations. Patients rece1vin11 therapeutic doses of Talwin
have experienced, in rare instances, hallucinations (usually visual}. disorientation, and confusion which have cleared spontaneously within a
period of hours. The mechanism of this reaction is not known. Such patients
should be very closely observed and vital signs checked. If the drug is reinstituted it should be done with caution since the acute CNS manifestations may recur.
Usa[te in Children. Because clinical experience in children under 12 years of
age 1s limited, administration of Talwin in this age group is not recommended .
Ambulatory Patients. Since sedation, dizziness, and occasional euphoria
have been noted, ambulatory patients should be warned not to o~erate
machinery, drive cars, or unnecessarily expose themselves to hazards.
Precautions: Certain Respiratory Conditions. Although respiratory depression has rarely been reported after oral administration of Talwin, the drug
should be administered with caution to patients with respiratory depression
from any cause, severely limited respiratory reserve, severe bronchial
asthma and other obstructive respiratory conditions, or cyanosis.
Impaired Renal or Hepatic Function. Decreased metabolism of the drug by
the liver in extensive liver disease may predispose to accentuation of side
effects. Although laboratory tests have not indicated that Talwin causes or
increases renal or hepatic impairment, the drug should be administered
with caution to patients with such impairment.
Myocardial Infarction. As with all drugs, Talwin should be used with caution
in patients with myocardial infarction who have nausea or vomiting.
Biliary Surgery. Until further experience is gained with the effects of Talwin
on the sphincter of Oddi, the drug should be used with caution in patients
about to undergo surgery of the biliary tract.
Patients Receiving Narcotics. Talwin is a mild narcotic antagonist. Some
patients previously given narcotics, including methadone for the daily treatment of narcotic dependence, have experienced withdrawal symptoms after
receiving Talwin.
CNS Effect. Caution should be used when Talwin is administered to patients prone to seizures; seizures have occurred in a few such patients in
association with the use of Talwin although no cause and effect relationship
has been established .
Adverse Reactions: Reactions reported after oral administration of Talwin
include gastrointestinal: nausea, vomiting; infrequently constipation; and
rarely abdominal distress, anorexia, diarrhea. CNS effects: dizziness, lightheadedness, sedation, euphoria, headache; infrequently weakness, disturbed dreamsi insomnia, syncope, visual blurring and focusing difficulty,
hallucinations see Acute CNS Manifestations under WARNINGS}; and rarely
tremor, irritability, excitement, tinnitus. Autonomic: sweating; infrequently
flushing; and rarely chills. Allergic: infrequently rash; and rarely urticaria,
edema of the face. Cardiovascular: infrequently decrease in bjood pressure,
tachycardia . Hematologic: rarely depression of white blood cells (especially
granulocytes}. usually reversible and usually associated with diseases or
other drugs which are known to cause such changes, moderate transient
eosinophiha. Other: rarely respiratory depression, urinary retention, toxic
epidermal necrolysis.
Dosage and Administration: Adults. The usual initial adult dose is 1 tablet
(50 mg.} every three or four hours. This may be increased to 2 tablets (100
mg.} when needed. Total daily dosage should not exceed 600 mg.
When antiinflammatory or antipyretic effects are desired in addition to
analgesia, aspirin can be administered concomitantly with Talwin.
Children Under 12 Years of Age. Since clinical experience in children under
12 years of age is limited, administration of Talwin i n this age group is not
recommended.
Duration of Therapy. Patients with chronic pain who have received Talwin
orally for prolonged periods have not experienced withdrawal symptoms
even when administration was abruptly discontinued (see WARNINGS}. No
tolerance to the analgesic effect has been observed. Laboratory tests of
blood and urine and of liver and kidney function have revealed no significant abnormalities after prolonged administration of Talwln.
Overdosage: Manifestations. Clinical experience with Talwin overdosage has
been insufficient to define the signs of this condition.
Treatment. Oxygen, intravenous fluids, vasopressors, and other suppcrtive
measures should be employed as indicated. Assisted or controlled ventilation should also be considered . Although nalorphine and levallorphan are
not effective antidotes for respiratory depression due to overdosage or unusual sensitivity to Talwin, parenteral naloxone (Narcan®, available through
Endo Laboratories} is a specific and effective antagonist.
Talwin is not subject to narcotic controls.
How Supplied: Tablets, peach color, scored. Each tablet contains Talwin
(brand of pentazocine} as hydrochloride equivalent to 50 mg. base. Bottles
of 100.
( 16231,)

Winthrop Laboratories, New York, N .Y. 10016
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A service to medical education from A. H. Robins:
Excerpted from Volume 2

offheG.I.

Senes

on physical examination
of the abdomen:

Normally palpable organs:
the edge of the liver descending,
on inspiration, below the costal
margin (AJ; the lower pole of the
right kidney (BJ; the abdominal
aorta (CJ; the descending colon
and the sigmoid (DJ; the ascending colon ( E); and occasionally
the bladder (though rising of
this organ beyond the pubis
does not necessarily indicate
disease).
Impossible to outline, unless
diseased , distended or enlarged :
the gallbladder, pancreas.
stomach, small intestine, transverse colon and spleen.

\'. ~
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The A . H . Robins G .I. Series consists of six booklets. designed to p rovide a Quick. yet comprehensive review o f basic procedures and practices in
G .I. medicine - with particular emphasis on the
:::.._
physical examination as performed in the office or
·-........:.
at bedside . If you have teac hing responsibilities.
--...._ _
limited Quantities are available: Part 1 - Inspection ,
Part 2 - Palpation, Part 3 - Percussion. Part 4 - Auscuffation. Part 5 Abdominal Pain a nd Part 6 - Differenllal D iagnosis of Abdominal
Disorders. Write to: The Medical Department. A. H . Robins Company.
1407 C ummings Drive. Richmond . Virginia 23220 .
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The A . H Robins G I Series consists of six book·
lets . designed to provide a quick. yet comprehen sive review of basic procedures and practices in
G .I. medicine - with particular emphasis on the
p h ysica l examination as performed in the office or
at bedside If you have teaching responsibilities .
~
limited Quantities are avai lable : Part 1 - lnspection.
Part 2 - Palpation . Part 3 - Percuss;on . Part 4 - Auscultation . Part 5 Abdominal Pam and Part 6 - D1fferent1at Diagnosis of Abdominal
Disorders. Write to : The Medical Department. A. H . Robins Company.
1407 Cumm ing s Drive . Richmond . Virginia 23220
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Normally palpable organs:
the edge of the liver descending ,
on inspiration, below the costal
margin (A); the lower pole of the
right kidney (BJ; the abdominal
aorta (CJ; the descending colon
and the sig moid (DJ; the ascending colon CEJ; and occasionally
the bladder (though rising of
this organ beyond the pubis
does not necessarily indica te
disease) .
Impossible to outline, unless
diseased , distend ed or enlarged:
the gallbladder, panc reas,
stomac h, small intestine, transverse colon and spleen.

each tablet.
capsule or 5 cc.
teaspoonful
each
Donnatal
of elixir
No. 2
(23% alcohol)
O. 1037 mg.
hyoscyam1ne sulfate
0. 1037 mg.
0.0194 mg .
atropine sulfate
0.0194mg .
0.0065 mg
hyoscine hydrobrom1de
00065mg.
(V.. gr.) 16.2 mg . (Y.! gr.) 32.4 mg.
Phe~obarb1tal
~arning may be habit forming)

each
Extentab
0.3111 mg.
0.0582 mg
0.0195mg.
(o/. gr.) 48.6 mg .

•

Brief summary. Adverse Reactions: Blurring of vision. dry mouth.
difficult urination , and flushing or dryness of the skin may occur
on higher dosage levels, rarely on usual dosage. Contraindications: Glaucoma; renal or hepatic disease; obstructive uropathy
(for example, bladder neck obstruction due to prostatic hypertrophy); or hypersensitivity to any of the ingredients.
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atropine sulfate
0 .0582 mg
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00065mg.
(JI.I gr.) 16.2 mg. ( YI! gr.) 32.4 mg. (o/. gr.) 48.6 mg.
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,w.irning may be habit forming)
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Brief summary. Adverse Reactions: Blurring of vision , dry mouth.
difficult urination. and flushing or dryness of the skin may occur
on higher dosage levels. rarely on usual dosage. Contraindications: Glaucoma; renal or hepatic disease; obstructive uropathy
(for example, bladder neck obstruction due to prostatic hypertrophy); or hypersensitivity to any of the ingredients.
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Before prescribing, please consult
complete product information, a summary of which follows:
Indications: Tension and anxiety

states; somatic complaints which are
concomitants of emotional factors; psychoneurotic states manifested by tension,
anxiety, apprehension, fatigue, depressive symptoms or agitation; symptomatic
relief of acute agitation, tremor, delirium
tremens and hallucinosis due to acute
alcohol withdrawal; adjunctively in skeletal muscle spasm due to reflex spasm to
local pathology, spasticity caused by
upper motor neuron disorders, athetosis,
stiff-man syndrome, convulsive disorders
(not for sole therapy).
Contraindicated: Known hypersensitivity Q the drug. Children under 6
months of age. Acute narrow angle glaucoma; may be used in patients with open
angle glaucoma who are receiving appropriate therapy.
Warnings: Not of value in psychotic
patients. Caution against hazardous
occupations requiring complete mental
alertness. When used adjunctively in convulsive disorders, possibility of increase
in frequency and/ or severity of grand mal
seizures may require increased dosage of
standard anticonvulsant medication;
abrupt withdrawal may be associated
with temporary increase in frequency
and/ or severity of seizures. Advise
against simultaneous ingestion of alcohol
and other CNS depressants. Withdrawal
symptoms (similar to those with barbitu·
rates and alcohol) have occurred following abrupt discontinuance (convulsions,
tremor, abdominal and muscle cramps,
vomiting and sweating). Keep addictionprone individuals under careful surveillance because of their predisposition to
habituation and dependence. In pregnancy, lactation or women of childbearing
age, weigh potential benefit against
possible hazard.
Precautions: If combined with other
psychotropics or anticonvulsants, consider carefully pharmacology of agents
employed; drugs such as phenothiazines,
narcotics, barbiturates, MAO inhibitors
and other antidepressants may potentiate
its action. Usual precautions indicated in
patientS severely depressed, or with latent
depression, or with suicidal tendencies.
Observe usual precautions in impaired
renal or hepatic function. Limit dosage to
smallest effective amount in elderly and
debilitated to preclude ataxia or oversedation.
Side Effects: Drowsiness, confusion,
diplopia, hypotension, changes in libido,
nausea, fatigue, depression, dysarthria,
jaundice, skin rash, ataxia, constipation,
headache, incontinence, changes in salivation, slurred speech, tremor, vertigo,
urinary retention, blurred vision. Paradoxical reactions such as acute hyperexcited states, anxiety, hallucinations,
increased muscle spasticity, insomnia,
rage, sleep disturbances, stimulation
have been reported; should these occur,
discontinue drug. Isolated reports of neutropenia, jaundice; periodic blood counts
and liver function tests advisable during
long-term therapy.
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If there's
good reason to
prescribe for
psychic tension...

When, for example,
reassurance and counseling
on repeated visits
are not enough

Effectiveness is
a good reason to
consider Valium
(diazepam)
2-mg,5-mg,
10-mg tablets

